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Abstract 
 
Terpenoids are the largest and structurally most diverse family of natural product. α-
pinene, a monoterpene found in turpentine, is a precursor to several high-value mono-
oxygenated terpenoids such as verbenone.  It is produced naturally through the Mg2+ -
dependent transformation of geranyl diphosphate (GDP) catalysed by (+)-α-pinene 
synthase (APS). 
 
Heterologous expression, purification and characterization of recombinant (+)-α-pinene 
synthase were performed. Several expression conditions and many purification methods 
were tried in order to get optimum results. After optimisation of His tagged α-pinene 
synthase (HAPS), chemoenzymatic synthesis of a simple two-step, one pot asymmetric 
synthesis from GDP of (+)-verbenone, an oxidation product of the monoterpene (+)-α-
pinene, that is used to control attacks of pine trees by bark beetles is described. This 
method generates (+)-verbenone from GDP in good yield and without the need to 
isolate the intermediate (+)-α-pinene. 
 
Then, synthesis of some chemically modified GDP analogues to obtain (+)-α-pinene 
analogues was performed. These engineered (+)-α-pinene analogues may display 
enhanced biological activities due to the potential improvement of their physical 
properties. 
 
Finally, site directed mutagenesis strategy was employed to HAPS to examine the 
potential catalytic role of several aromatic amino acids, in stabilizing the carbocationic 
intermediates generated in the active site of HAPS during the natural conversion of 
GDP to the monoterpene (+)-α-pinene. 
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1.1 General Introduction 
 
Terpenoids constitute the largest family of natural products and to date, the structure 
and stereochemistry of more than 55,000 different members have been characterized.1 
They represent the most diverse family of natural products; yet they all formally derived 
from isopentenyl diphosphate (IDP, 1).2 In nature, terpenes are biosynthesized by a class 
of C-C bond forming enzymes called terpene synthases (or cyclases). Most of them are 
considered to be high fidelity catalysts since they often generate a unique hydrocarbon 
product with remarkable structural and stereochemical precision. Remarkably however, 
the sesquiterpene synthases γ-humulene and δ-selinene synthases give rise to more than 
30 and 50 sesquiterpenes (C15) respectively.3 
 
Isopentenyl diphosphate (IDP, 1) and dimethylallyl diphosphate (DMADP, 2) are 
considered as the universal precursors of isoprenoids in all living organisms (Scheme 
1.1).4 The substrates of terpene synthases, namely geranyl diphosphate (C10, GDP, 4), 
farnesyl diphosphate (C15, FDP, 5) and geranylgeranyl diphosphate (C20, GGDP, 6)  
are formed by linear head to tail chain elongation reactions  involving the C5 
diphosphates 1 and 2.5 In contrast, squalene (C30, 7), and phytoene (C40, 8) derived 
from the alternative head-to-head condensation of two molecules of 5 or 6 
respectively.6-8  
 
The chain elongation reaction mechanism comprises DMADP (2) ionization, with 
formation of an allylic carbocation that further reacts with the double bond of IDP (1). 
This electrophilic addition reaction yields a tertiary carbocation which is quenched by 
stereospecific proton elimination to geranyldiphosphate (4).9  
 
A second chain elongation reaction with an additional molecule of IDP (1) and geranyl 
diphosphate (4) thus yields farnesyl diphosphate (5) (Scheme 1.2).10  This reaction can 
be further extended to produce geranylgeranyl diphosphate (6) by the addition of one  
molecule of IDP (1) and the loss of diphosphate ion. These elongation products are, the 
universal precursors of all mono-, sesqui-, and diterpenes.11 The geometry of the double 
bonds in all these linear precursors is trans- (e.g respectively GDP, FDP, GGDP). Other 
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chain elongation terpene synthases could generate Z- isomers in longest chain prenyl 
diphosphates (e.g. natural rubber).12 
 
 	  
	  	  	  
 
Scheme 1.1: Biogenetic scheme for the formation of the main isoprenoid diphosphates GDP (4), FDP (5) 
and GGDP (6) series 
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Scheme 1.2: Biosynthesis of geranyl (4) and farnesyl (5) diphosphates via head to tail chain elongation 
reaction by IDP (1) and DMADP (2). 
 
1.2 The biological and ecological functions of terpenes 
 
Terpenoids comprise a vast number of bioactive compounds that play different roles in 
nature. Primary metabolites are compounds required for reproduction or growth, while 
those that are not essential for the basic performance of growth and development are 
defined, as secondary metabolites.13 In plants, terpenoids act as hormones  
(gibberellins), photosynthetic pigments (carotenoids), electron carriers (ubiquinone) and 
structural components of membranes (phytosterols).14  In addition to these universal 
functions, many terpenes serve in communication and defense. For example, bark beetle 
infestation with the associated fungal infections in plants pose a major threat to conifer 
populations worldwide.15 Terpenoids are also very useful and available in large number 
as essential oils, resins, and waxes, providing for commercially useful products such as 
solvents, flavourings, fragrances, coatings and synthetic intermediates.16 For artificial 
purposes some terpenoids are employable as raw materials for pharmaceuticals (e.g. 
artemisinin, taxol) or agrochemicals (pyrethrins, azadirachtin).14,17-18 
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Monoterpenoids are non-nutritive dietary components, usually found in plants and 
insects as essential oils. However they have a high economic value as flavours and 
fragrances.19 Limonene (11) is extracted from orange peel oil, and has been shown to 
prevent several kinds of cancer in rodents.20 In natural and alternative medicine, (-)-
limonene is marketed to relieve gastroesophageal reflux and disease heartburn.21 Apart 
from being used as a solvent, limonene is now targeted as a biofuel.22 (+)-α-Pinene (12) 
has been found to act as a sex pheromone in some insects, attracting female bark 
beetles.15 Recent publications have also revealed that verbenone (13), an oxidation 
product of verbenol,  plays an important role as dispersal pheromone, and protects high-
value pine trees from the destructive mountain pine beetle.15 Verbenone (13) is a 
bicyclic monoterpenoid ketone, useful as a chiral synthon in syntheses of natural 
terpenoids, including the total synthesis of the anti-cancer agent taxol.23 Furthermore, 
this bioactive enone has been reported as an inhibitor of acetylcholine esterase and 
hence has potential for the treatment of early stage Alzheimer’s disease.24 In addition, 
verbenone is utilized in perfumery, aromatherapy, and herbal remedies.25 Other 
bioactive monoterpenoids include camphor (14), thymol (15) and cymene (16) (Figure 
1.1) which are used as antimicrobial agents.26  
 
 
 
Figure 1.1: Structures of cyclic monoterpenes limonene (11), α-pinene (12), cymene (16) and terpenoids 
verbenone (13), camphor (14), thymol (15). 
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Sesquiterpenoids have been used for many years in traditional medicines as therapeutic 
agents.27 A good example is the tetracyclic artemisinin (17), a sesquiterpenoid  
endoperoxide lactone obtained from Artemisia annua. This natural product has been 
used in China as an antimalarial and antipyretic drug.28 Modifications to the parent 
artemisinin structure, other than the peroxide lactone moiety, retain or even improve the 
pharmacological properties of artemisinin. The characteristic peroxide moiety is 
nevertheless essential for anti-malarial activity.29 For example dihydroartemisinin (18) 
is more potent than the parent compound.30 Pentalenolactone (19) is another 
sesquiterpenoid formally derived from the hydrocarbon pentalenene and which 
possesses antibiotic properties (Figure 1.2).31 
 
 
 
Figure 1.2: Structures of farnesyl diphosphate (5), artemisinin (17), dihydroartemisinin (18) and 
pentalenolactone (19).  
 
Other members of the sesquiterpene family of natural products have been reported to 
have fungicidal activity against many species of phytopathogenic fungi.32 For example, 
d-cadenine (20) and 5-epi-aristolochene (21) are the precursors of the defensive 
phytoalexins in gossypol (22) and capsidiol (23) biosynthesis (Figure 1.3), which act 
against fungal infection in cotton and tobacco plants respectively.33 Gossypol is a 
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noncompetitive inhibitior of calcineurin, a calcium dependent serine/threonine 
phosphatase involved in immune response and neural and muscle development.34 The 
dimer 22 has also been investigated as a potential male contraceptive.35  
 
As with the other groups of terpenoids, diterpenoids possess 4 units of isoprene, and 
have quite a few different uses both in nature and in medicine. Paclitaxel (24), also 
known by its original brand name Taxol, is a compound extracted from the Pacific yew 
(Taxus brevifolia) with remarkable antitumour and antileukemic activity. Diterpenoid 
(24) has a unique mechanism of action, because it induces very stable but dysfunctional 
microtubules thereby hindering the rapid cell division characteristic of malignant cell 
lines. Paclitaxel has varying antineoplastic activities; it has been successfully used in 
the treatment of ovarian cancer, metastatic breast cancer, lung cancer, carcinoma of the 
head and neck, malignant melanoma and other human neoplasms.36-37 
 
 
 
Figure 1.3: Structures of δ-cadinene (20), 5-epi-aristolochene (21) precursors of gossypol (22) and 
capsidiol (23). 
 
 
The phytoalexin casbene (25), a macrocyclic hydrocarbon, produced in high levels 
when bean plants are under microbial attack, has both antibacterial and antifungal 
properties (Figure 1.4).38   
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Figure 1.4: Structures of paclitaxel (24) and casbene (25)  
 
 
Sterols and carotenoids are growth regulators often classified as primary metabolites.39 
Sterols are widely spread among organisms and all of them derived from the C30 linear 
terpene squalene (7), itself derived from two molecules of FDP (5) (Scheme 1.1). The 
squalene analogue, squalene oxide (26), undergoes enzyme-catalysed cyclisation to 
afford lanosterol (27).40-41 The major sterol in animals is cholesterol (28), with 
ergosterol (29) dominating in fungi, plant sterols include stigmasterol (30) and sitosterol 
(31) (Scheme 1.3). In animals, cholesterol is the source of steroidal metabolites such as 
sexual hormones, bile acids, and vitamin D. Importantly steroids are implicated in 
maintaining the membrane fluitidy and permeability.41 Recent research indicates an 
important role for cholesterol (28) in several diseases such as the development of 
cardiac and vascular diseases, dementias, diabetes and cancer.42-43  	  
	  	   24 25 
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Scheme 1.3: Generation of animal, fungal and plant sterols lanosterol (27), cholesterol (28), ergosterol 
(29), stigmasterol (30) and sitosterol (31) 	  	  
More than 600 different carotenoids have been isolated and characterized from natural 
sources. Carotenoids are biosynthesized from two GGDP (6) units. Phytoene (8), the 
C40 terpene precursor, is the parent molecule of carotenoids.44 This group of molecules 
is central for the absorption of light in photosynthetic organisms due to their highly 
conjugated structures.45 Phytoene (8) can also be converted to vitamin A (32, retinol), 
which has important functions in the vision process and resistance to infectious disease 
in mammals (Figure 1.5).46-48 
 
 
 
 
 
 
 
Figure 1.5: Structure of vitamin A (32) 
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Quinones are another type of terpenoid natural product essential in biochemical 
reactions as electron transfer mediators. Oxidative phosphorylation and photosynthesis 
are a pair of examples.49-50 The structure contains a polyisoprene chain, the length of 
which is species-specific.51 Quinones can undergo facile and reversible electron transfer 
reactions (Figure 1.6).52 
 
 
 
Figure 1.6: Structures of quinones in different redox states. 
 
 
1.3 Biosynthesis of terpenes 
 
The initial postulate of the “isoprene rule” put forward by Wallach stated that most 
terpenoids could be hypothetically constructed by a repetitive joining of isoprene (2-
methyl-1,3-butadiene, 3) units and possess the formula C5H8 or (C5H8)x.30 The 
“biogenetic isoprene rule” was later proposed by Leopold Ruzicka, which did not 
address the precise character of biological precursors and assumes only that they are 
“isoprenoid” in structure.55 The carbon skeleton of terpenes is composed of isoprene 
units linked either in a regular head to tail fashion or in an irregular sequence.55 
Isoprene units joined in irregular sequence are encountered less frequently, and only a 
few closely related organisms synthesise these compounds. For example, a number of 
OH
OH n
O
O n
O
O n
OH
OH n
O
O n
O
O n
plastoquinone
menaquinone
(QH2) (QH ) (Q)
	   11	  
natural monoterpene structures contain carbon skeletons, which, although obviously 
derived from isoprene C5 units, do not seem to fit the regular head-to-tail coupling 
mechanism (Figure 1.7). These structures are named irregular monoterpenes.56 
 
 
 
Figure 1.7: Examples of regular and irregular monoterpene skeletons 
 
The isoprene unit can be identified in most terpenoid structures, as a vitally important 
component but 3 itself is not the biological precursor of terpenoids. Rather, two 
biosynthetic equivalents of isoprene, isopentenyl diphosphate (IDP) (1) and 
dimethylallyl diphosphate (DMADP) (2), are indeed the building blocks of 
isoprenoids.57 There are two known pathways used to produce the IDP (1) and DMADP 
(2) in nature, the mevalonic acid  (MVA) and non-mevalonate (or deoxyxylulose 
phosphate, DXP) pathway58 The mevalonic acid pathway (Scheme 1.4) generally takes 
place in the cytosol and is mainly responsible for the formation of sesquiterpenes and 
triterpenes. Mammals, higher plants, fungi and some bacteria use this pathway to 
generate IDP (1) and DMADP (2). The non-mevalonate pathway (Scheme 1.5) takes 
place in the plastids and is responsible for the formation of monoterpenes, diterpenes 
and tetraterpenes.59  
 
1.3.1 Mevalonic acid (MVA) pathway 
 
This pathway starts with three units of acetyl-CoA (33). The first two units of acetyl-
CoA are linked in a Claisen condensation reaction catalysed by acetoacetyl-CoA 
synthase with the release of coenzyme A to afford the acetoacetyl-CoA (34). A third 
molecule of acetyl-CoA is added in an aldol-like reaction with the help of β-hydroxy-β-
methylglutaryl-CoA (HMG-CoA) synthase to afford the product, HMG-CoA (35).59 
HMG-CoA reductase is the enzyme that catalyses the reduction of the thioester group of 
HMG-CoA to the primary alcohol, (3R)-mevalonic acid  (37). The cofactors used in this 
Regular monoterpene skeleton Irregular monoterpene skeletons
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reaction are two equivalents of NADPH.60
 
The two hydroxy groups of (3R)-mevalonic 
acid (37) are phosphorylated (tertiary alcohol) and diphosphorylated (primary alcohol) 
by three molecules of ATP to yield mevalonic acid triphosphate (39). The final product 
IDP (1) comes from the decarboxylation of mevalonic acid triphosphate. IDP (1) and 
DMADP (2) are interconvertible by stereospecific isomerisation. It was shown by 
tritium-labelling experiments that only the pro-R proton on C2 of 2 is involved in the 
isomerisation process (Scheme 1.4).
61   
 
 
 
 
Scheme 1.4: Mevalonic acid pathway to IDP (1) and DMADP (2). 
 
 
1.3.2 Non-mevalonate pathway 
 
This pathway was discovered by Rohmer and co-workers at the end of the last century, 
using 13C NMR labeling experiments.62,63 A whole series of 13C-labeled glucose 
isotopomers were used as minimal feedants and converted into a series of  hopanoids by 
the bacterium Zymomonas mobilis - the results showed that the carbon skeleton was 
derived from a C2 subunit formed from pyruvate (40) by decarboxylation and a C3 
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subunit derived from a triose phosphate derivative (Scheme 1.5).62,63 Incorporation of 
13C- labeled pyruvate and 13C- labeled glycerol using E. coli mutants, lacking a single 
enzyme of the triose phosphate metabolic pathway, showed that D-glyceraldehyde 
phosphate (GAP, 41 ) together with pyruvate (40) are the precursors of DMAPP and 
IDP in the alternative pathway.64  This metabolic route was found to occur in the 
chloroplasts of algae, cyanobacteria, eubacteria and apicomplexa. This pathway is also 
named as the pyruvate/glyceraldehyde-3-phosphate pathway or sometimes as the MEP 
pathway, due to the fact that pyruvate (40) and D-glyceraldehyde-3-phosphate (41) are 
the starting compounds of this pathway and that 2-C-methyl-D-erythritol-4-phosphate 
(MEP) (44) is an important intermediate in the pathway. 
 
1-Deoxy-D-xylulose 5-phosphate (DXP) (42) is formed from pyruvate and 
glyceraldehyde 3-phosphate by thiamine diphosphate mediated decarboxylation of 
pyruvate, yielding an enamine. Nucleophilic attack of glyceraldehyde 3-phosphate by 
the enamine, followed by the release from thiamine diphosphate generates DXP, which 
is a key intermediate in the biosynthesis of pyridoxal phosphate and thiamine. After a 
pinacol-like rearrangement of DXP, and NADPH, a reaction catalyzed by DXP-
reductoisomerase giving 2-C-methyl-D-erythritol-4-phosphate (MEP, 44) as the 
product. The formation of 2-phospho-4-cytidinediphosphate-2-C-methylerythritol (45) 
takes place by reaction of MEP with cytidine triphosphate (CTP) and is followed by 
ATP-dependent phosphorylation.65 The two final dehydration steps are catalysed by the 
2-C-methyl-D-erythritol 2,4-cyclodiphosphate reductase and 4-hydroxy-3-methylbut-2-
enyl diphosphate reductase respectively, resulting in DMADP (2) and IDP (1) as the 
final products. 
 
Since animals, fungi and yeast do not use the non-MVA pathway at all,66 detailed 
research on the enzymes involved in the non-MVA pathway are targets for antibacterial, 
herbicidal or antimalarial drug therapies.66,67  
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Scheme 1.5: The non-mevalonate pathway to IDP and DMADP 
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1.4 Terpene synthases 
 
Terpene synthases catalyse some of the most complex reactions found in chemistry and 
biology. They are divalent metal cation dependent enzymes. The divalent metals are 
usually Mg2+ or Mn2+, with Mg2+ being used most often.68 As an exception, the presence 
of metal ions are not absolutely required for class II terpenoid synthases (vide infra).69 
The essential function of a terpene synthase is to catalyse the formation of terpenoid 
products from linear polyisoprenoid substrates in a reaction that usually shows 
distinguished structural and streochemical precision. Terpenoid synthases can be 
divided into two classes, depending on the first step of the enzymatic reaction.70 To start 
catalysis, class I terpene synthases generate a carbocation by the loss of the diphosphate 
group. Isoprenyl diphosphate synthases, monoterpene and sesquiterpene synthases 
belong in this grouping. Class II terpenoid synthases generate the initial carbocation by 
protonation of a carbon-carbon double bond or an epoxide. Enzymes from this class 
include some diterpene, triterpene and tetraterpene synthases.70 The carbocationic 
intermediates are sheltered from the bulk solvent in a hydrophobic pocket that provides, 
in addition, an environment capable of stabilising specific carbocations, thus it might be 
expected that the active sites of these proteins typically contain several aromatic amino 
acids.71-73 
 
Despite often insignificant overall sequence similarity (typically below 25-35%) 
bacterial, fungal and animal terpene synthases all share a common fold, the class-I 
terpenoid fold, an α-barrel usually containing between 10 and 12 α-helices arranged in 
anti-parallel fashion.74,75 Plant terpene synthases however, do have significant sequence 
similarity amongst themselves (50-90%).76 For example, δ-selinene synthase and γ-
humulene synthase both from the gymnosperm Abies grandis have 83% sequence 
similarity.77 Substrate specificity varies among terpene synthases. GDP (4) and GGDP 
(6) are the exclusive substrates accepted by monoterpene and diterpene synthases 
respectively. On the other hand, sesquiterpene and triterpene synthases generally do not 
exhibit this strict substrate selectivity. For example, the sesquiterpene synthase (E)-β-
farnesene synthase can use the monoterpene linear precursor GDP (4) to synthesise 
monoterpenes such us limonene (6), terpinolene (51) and myrcene (52). Some terpene 
synthases produce only one major product, for instance, δ-cadinene synthase makes δ-
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cadinene (15) as the sole product.
78 
However, some other terpene synthases produce 
more than one product, aristolochene synthase from P. roqueforti produces in addition 
to the major product aristolochene (16), two side products, valencene (53) and 
germacrene A (54).
79 
γ-Humulene synthase from Grand Fir produces 52 different 
products.
77 
 
 
 
Figure 1.8: Structure of terpinolene (51), myrcene (52), valencene (53) and germacrene A (54) 
 
 
Terpene synthase cDNAs encode proteins of 550-850 amino acids; corresponding to 
relative molecular masses of 50-100,000 Da. In general monoterpene synthases are 600-
650 amino acids in length80,81 and are 50-70 residues larger than their sesquiterpene 
synthase counterparts produced in the cytosol.82-84 The size difference is due to the 
presence of an N-terminal plastid-targeting peptide in monoterpene synthases. 
Diterpene synthases are approximately 200 amino acids longer than sesquiterpene 
synthases due to a conserved N-terminal domain,76 is often referred to as the conifer 
diterpene internal sequence (CDIS) domain due to high conservation in diterpene 
synthases. 
 
Despite the differences in reaction mechanism, the classes Ι and II enzymes clearly 
belong to the terpene synthase gene family.76 Several residues conserved amongst 
terpene synthases have been identified by sequence alignment, the most prominent of 
which are the amino acid residues of the metal binding motifs. Class I terpene synthases 
contain two metal motifs at the entrance of the active sites: the “aspartate-rich” (N, D) 
DXX (D/E) metal binding motif, and less specific (L,V) (V,L,A)-
(N,D)D(L,I,V)X(S,T)XXX, which is usually abbreviated as “NSE/DTE” motif, in 
51 52 53 54
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which the boldface residues are implicated in binding three magnesium ions.75,85 Class I 
terpene synthases have a conical active site that is bounded by about five helices.86 The 
conical shape of the active site is imposed by the helices and the loops connecting them. 
The loops are comparatively long at the top and short at the bottom of the active 
site.74,75 
 
Protonation-dependent class II terpene synthases contain only a DXDD metal binding 
motif, in which the central aspartate residue acts as a proton donor that generates the 
initial carbocation.87 The squalene-hopene synthase (triterpene synthase) from 
Alicyclobacillus belongs to this class.86 The bifunctional abietadiene synthase from the 
Grand Fir shows distinct cyclisation reactions catalysed by its class I and class II 
synthase domains, but the triple-domain taxadiene synthase from Taxus brevifolia 
functions as a class I terpenoid synthase as the conserved DXDD motif was absent.  
Plant synthases such as (+)-bornyl diphosphate synthase and 5-epi-aristolochene 
synthase contain both domains; only the class 1 domain is catalytically active.88   
 
1.4.1 Crystal structures of terpene synthases 
 
Several crystal structures of terpene synthases have been solved to date and the number 
grows each year. Aristolochene synthase from Penicillium roqueforti89 and Aspergillus 
terreus,90 5-epi-aristolochene synthase from Nicotiana tabacum,91 farnesyl diphosphate 
synthase from Staphylococcus aureus, pentalenene synthase from Streptomyces 
UC5319,74 bornyl diphosphate synthase from Salvia officinalis,88 limonene synthase 
from Mentha spicata92 are representative examples (Figure 1.9)  
 
The crystal structure of aristolochene synthase from Aspergillus terreus illustrates the 
important tertiary structural features from microbial sesquiterpene synthases. The 2.2 Å 
crystal structure reveals a tetrameric quaternary structure with a characteristic class I 
terpene synthase fold. There are a total of thirteen α-helices, six of which form the 
active site cleft.90 The 2.5 A resolution crystal structure of aristolochene synthase from 
Penicillium roqueforti was the first of the fungal terpenoid synthases solved. This 
enzyme has eleven α-helices in the structure of which six form the active site cavity. 
The overall structure of both enzymes is very similar; they share 61% amino acid 
	   18	  
sequence identity. 
 
All plant sesquiterpene synthases contain an additional N-terminal domain. The 5-epi-
aristolochene synthase from Nicotiana tabacum catalyses the cyclisation of farnesyl 
diphosphate to form the bicyclic hydrocarbon 5-epi-aristolochene.91 This was the first 
example of a plant sesquiterpene crystal structure. The enzyme was complexed with 
two substrate analogues, farnesyl hydroxyphosphonate and trifluorofarnesyl 
diphosphate. They revealed the coordination of three Mg2+ ions to the metal binding 
motifs discussed earlier.  
 
Solution of the X-ray crystal structure of pentalenene synthase showed that this enzyme 
also folds into a typical class I terpenoid synthase structure. Its tertiary structure is 
defined by 11 α–helices, 5 of which envelop the active site cavity. The lower section of 
the enzyme active site cleft is hydrophobic and contains a handful of aromatic and 
aliphatic residues, but the upper part is more hydrophilic and consists of polar side 
chains. A similar fold to that of pentalenene synthase is also uncovered in farnesyl 
diphosphate synthase, even though only 15% sequence identity is found between these 
two enzymes.74 
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Figure 1.9: Ribbon diagram illustration of the crystal structures of some terpene synthases 
 
 
Limonene synthase is similar to 5-epi-aristolochene synthase in having two helical 
domains: a C-terminal domain with the active site and an N-terminal domain of 
unknown function.92 The N-terminal domain folds back right through the C-terminal 
domain to form a cap in the active site. This is postulated to shelter reactive 
carbocationic intermediates from solvent. A study of intron conservation patterns in 
terpenoid synthase genes has denoted that modern terpenoid synthases evolved from an 
ancestral enzyme in which both domains were catalytically active.93 A flexible 
structure, specifically in the active site, would be expected for an enzyme that binds two 
structurally different diphosphates such as GDP (4) and LDP (55) during the reaction. 
This may due to the tandem arginine residues R58 and R59, positioned in the N-
terminal strand. The 2.7 A resolution crystal structure reveals a homodimeric quaternary 
aristolochene synthase 
(1DGP.pdb)                                  
aristolochene synthase 
(2OA6.pdb)                                                              	  
5-epi-aristolochene synthase  
(5EAS.pdb)
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structure with two forms of liganded substrate (2-fluorogeranyldiphosphate) and 
intermediate (2-fluorolinalyldiphosphate) analogues. 
 
Two tandem arginine pairs have been found in many monoterpene synthases.88 
Polypeptide deletion studies on the limonene synthase of Mentha spicata revealed that 
the enzyme activity was not affected by deletion of the N-terminal region preceding this 
tandem argine pair. Deletion of this motif made the limonene synthase unable to accept 
GDP (4) as a substrate although linalyl diphosphate (LDP, 55) was still usable by the 
deletion mutant, suggesting that the arginine motif might participate in the isomerisation 
of GDP (4) to linalyl cation.92 The N terminal polypeptide domain is involved in many 
hydrogen bond interactions with the C-terminal domain including R56 with D355.  
 
Bornyl diphosphate synthase 
 
The first crystal structure of a monoterpene synthase was solved for (+)-bornyl 
diphosphate synthase (BDPS) from Salvia officinalis.88 This enzyme crystallised as a 
homodimer - each monomer containing two α-helical domains. The C-terminal domain 
contains the characteristic class I terpene fold. The N-terminal domain forms an α-
barrel similar to that of 5-epi-aristolochene synthase.91 This domain has no well defined 
function; nevertheless, the disordered N-terminal polypeptide segment caps the active 
site in the C-terminal domain upon ligand binding and becomes ordered.  
 
 
Figure 1.10: Stereoplot of the native BDPS monomer, including the active site (blue).88 
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The C-terminal domain of BDPS consists of 12 α-helices, six of which (C, D, F, G, H 
and J) are responsible for the hydrophobic active site cleft. The aspartate-rich 
D351DIYD motif is positioned at the C-terminal end of helix D (Figure 1.10). Asp351 
and Asp355 coordinate to Mg2+A and Mg2+C. Asp 496, Thr500 and Glu504 chelate 
Mg2+B on the opposite site of the active site cleft as the second metal binding motif 
(DTE). 
 
Coordination of PPi- Mg2+3 by BDPS activates several conformational changes in the 
protein, which presumably lead to an active site cavity secluded from bulk solvent. The 
disorder in the unliganded structure (N-terminus E50-A63 and loop segments D227-
D234, T500-D509 and F578-S583) becomes ordered and caps the active site in the 
enzyme-ligand complex. A single water molecule (water 110) was found to be trapped 
in the active site cavity after the conformational change.  
 
The structures of BDPS complexed with aza analogues of presumed carbocationic 
intermediates (3-aza-2,3-dihydro-geranyldiphosphate (56), 2-azabornane (57), 7-aza-
7,8-dihydro-limonene (58)) (Figure 1.11) reveal fundamentally identical molecular 
recognition of the diphosphate moiety.94,95 Comparisons between BDPS and aza 
analogues of putative intermediates and also the product, indicate that the hydrophobic 
active site serves as a template for substrate and intermediates through a complicated 
cyclisation process, even though the diphosphate group is rigidly bound. Several 
aliphatic and aromatic residues in the active site, including W323, I344, V452 and F578 
along with water molecule number 110 line the hydrophobic active site. This water 
molecule makes hydrogen bonds to the diphosphate group of 56 and the backbone 
carbonyl of S451 and the side chain of Tyr-426. This suggests that it cannot easily react 
with carbocation intermediates to prematurely quench the cyclisation cascade. Perhaps, 
water number 110 could serve as a diphosphate-assisted general base to account for the 
generation of cyclic olefin side products such as pinene (12), camphene (14), and 
limonene (11).88 
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Figure 1.11: Structures of 3-aza-2,3-dihydro-geranyldiphosphate (56), 7-aza-7,8-dihydro-limonene (57) 
and 2-azabornane (58)  
 
 
1.5 Monoterpene synthases: Reaction mechanisms 
 
It has been established that monoterpene synthases possess a common carbocationic 
reaction mechanism initiated by the divalent metal ion-dependent ionization of the 
substrate.96 They have Km values in the low micromolar range and have relatively low 
turnover numbers (<1 s-1).97-99 Most monoterpene synthases are multiproduct enzymes 
with great active site flexibility to generate product diversity, but they are generally 
specific in using only C10 isoprenyl diphosphate substrates, GDP (4), linalyl 
diphosphate LDP (55)), or neryl diphosphate NDP (59) (cis-isomer of 4) (Figure 1.12) 
with product diversity often including several monoterpene structural types (Figure 
1.13). GDP is generally considered the natural C10 substrate of monoterpene 
synthases.97,98 However recent characterisation of enzymes from cultivated tomato 
plants have showed that they use NDP (59) as the substrate of monoterpene 
production.100 Structural characterisation of monoterpene synthases from their native 
plant sources has demonstrated that ‘lower eukaryote’ like liver-worts, ferns, and algae 
resemble their higher plant counterparts in enzymological characteristics.101,102 These 
results suggests a common plant ancestor.  
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Figure 1.12: The predominant monoterpene precursor, GDP (4) and its cis-isomer NDP (59) 
 
 
 
 
 
Figure 1.13: Product diversity of monoterpenes 
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1.5.1 Ionisation and isomerisation of GDP 
 
GDP (4), the major precursor of the monoterpenoids, undergoes an ionisation and 
isomerisation to enzyme-bound linalyl diphosphate (LDP, 55). For a monoterpene 
synthase to produce cyclic monoterpene products it must first overcome the topological 
impediment to direct cyclisation of geranyl diphosphate, imposed by the trans geometry 
of the C2–C3 double bond, by way of a preliminary isomerisation step to permit 
subsequent cyclisation (Scheme 1.6). After rotation about the C2–C3 bond to afford the 
cis conformer, LDP is itself ionized with C6–C1 ring closure to provide the 
corresponding α-terpinyl carbocation (79) from which all cyclic monoterpenes are 
derived. These early reaction steps appear to be common to all monoterpene 
cyclisations, with subsequent steps involving termination of the reaction either by 
deprotonation, nucleophilic capture, further electrophilic cyclisation to the remaining 
double bond, hydride shift, or Wagner–Meerwein rearrangement before termination. 
Alternatively, a deprotonation can occur beore cyclisation leading to acyclic 
monoterpenes such as myrcene. Acyclic monoterpenes are formed from either GDP or 
LDP via carbocations.103-106 In order to prove the electrophilic nature (ionisation) of the 
cyclisation reaction, incubations were carried out using 2-fluoro-GDP (80) and 2-
fluoro-LDP (81).107,108 The results from these experiments showed 100-fold rate 
suppression, and displayed evidence of the electrophilic nature of the cyclisation 
reaction involving either GDP (4) or LDP (55). Kinetic analysis with these analogues 
using purified (-)-limonene synthase and (+)-bornyl diphosphate synthase revealed that 
both fluoro analogues are competitive inhibitors.109 This provided additional compelling 
evidence showing that both ionisations occur in the same active site. 
 
 
Scheme 1.6:  Production of cyclic α-terpinyl cation (79) from GDP (4) 
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The mechanism of the acyclic monoterpene reactions proceed by ionisation into geranyl 
cation followed by proton loss to form (E)-β-ocimene (61)110 and myrcene (52),81,110 or 
addition of water to form geraniol (63)111 or linalool (62).112 These acyclic 
monoterpenes can be derived also from the linalyl cation (Scheme 1.7).  
 
 
 
 
Scheme 1.7: Examples of carbocationic reactions leading to cyclic monoterpenes.96 
 
 
The α-terpinyl cation is an important intermediate involved in the formation of all 
cyclic monoterpenes. From this intermediate, proton loss leads to limonene (11)112, 113 or 
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terpinolene (51), or if water is involved α- terpineol (66).105, 114 In contrast, internal 
addition leads to 1,8-cineole (67). A [1,2]- or [1,3]-hydride shift of the α-terpinyl cation 
followed by proton loss yields the terpinene (9) and phellandrene (64) products.114,115 
The thujane monoterpene produced by a [1,2]-hydride shift followed by cyclopropyl 
ring closure and tertiary cation quench by deprotonation, yields in the case,  α-thujene 
(70) and sabinene (71) or if by water capture sabinene hydrate (72). The α-terpinyl 
cation withstands additional cyclisations resulting from electrophilic attack of the 
carbocationic centre on one of the carbon atoms of the remaining double bond. A 
Markonikov addition (2,7-cyclisation) to α-terpinyl cation initiates formation of the 
pinyl cation, which undergoes proton loss to yield α-pinene (12) or β-pinene (13).116,117 
Anti-Markovnikov addition (3,7-cyclisation) of α-terpinyl cation  produces the bornyl 
cation, and diphosphate capture leads to bornyl diphosphate (73).118  (74) and camphene 
(14).119 Fenchol (78) is formed from the pinyl cation, via Wagner-Meerwein 
rearrangement and water quench.117 Wagner-Meerwein rearrangement (6,2-
rearrangement) of the bornyl cation lead to isocamphyl cation and deprotonation results 
camphene (14). A 5,7-closure of α-terpinyl cation   forms a cyclopropyl ring leading to 
3-carene (75).120  
 
 
1.5.2 (+)-α-Pinene synthase 
 
(+)-α-Pinene synthase catalyses the metal ion-dependent ionisation and isomerisation of 
GDP (4) to (+)-α-pinene (12). The proposed enzyme catalysed mechanism involves 
ionisation and isomerisation of this substrate to enzyme bound linalyl diphosphate (55) 
(Scheme 1.8), rotation about C2-C3, a second ionization, and cyclisation to the α-
terpinyl cation, to form the first cyclic intermediate en route to both monocyclic and 
bicyclic products. Electrophilic addition of the α-terpinyl cation to the 2,3-double bond 
and proton elimination generates (+)-α-pinene.116,117 
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Scheme 1.8: Proposed mechanism for the conversion of GDP (4) to α-pinene (12)  
 
 
In order to gain structural information about the (+)-α-pinene synthase from loblolly 
pine (Pinus taeda), computer modeling was needed because a crystal structure of this 
synthase is not yet available.121 The structures of tobacco 5-epi-aristolochene synthase 
and bornyl diphosphate synthase were used as templates to construct the (+)-α-pinene 
synthase homology model. The first 50-60 amino acids are high in serine and threonine 
content and low in acidic residues.121 The R65R66 tandem arginine pair was judged to 
play a role in the isomerisation step. The metal binding motif D379D380IYD383 and the 
highly conserved tandem tryptophan pair W329W330 are all structural repeats present 
commonly in monoterpene synthases. 
 
(+)-α-Pinene synthase, both native and recombinant, requires K+ for optimum activity. 
The predicted active site is distinguished by the conserved aspartate residues (379, 383, 
524) and conserved arginines in close vicinity to the diphosphate moiety. Several 
aromatic residues provide a deep pocket underneath these charged residues.121 This 
above mentioned computer model provides a tool to investigate structure-function 
relationships in α-pinene synthase the precursor of both verbenol and verbenone  
 
Bark beetle infestations pose a major threat to conifer populations worldwide122 with 
millions of acres of pine trees having been lost due to attacks by mountain pine beetles 
such as Dendroctonus ponderosae.123 Several factors have contributed to recent 
outbreaks of these insects.123,124 Many years of drought caused a decline in the defenses 
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of pine tree and warmer than average winters allowed a greater number of beetle larvae 
to survive.124 These beetles produce aggregation and anti-aggregation pheromones that 
modulate the beetle population density on the trees, many of these are monoterpenoids 
or monoterpenoid derivatives.124 These monoterpenoid pheromones are messenger 
chemicals (semiochemicals). The male beetle uses (+)-α-pinene (12) produced by the 
tree for host selection and then converts it to verbenol, which acts as an attractant for 
female beetles. The beetles then produce the oxidation product (+)-verbenone (13), 
which acts as a dispersal pheromone to modulate the density of the attack.15,124 In a 
program to limit tree damage from beetle infestation, foresters have hung small bags of 
synthetic verbenone on trees as a beetle repellant.123 When the beetle populations are 
low, trees systematically attack by drowning the beetles in sap. If that fails the trees 
produce defensive resins that kill maturing beetle larvae.125,126  
 
Verbenone (13) is a bicyclic ketone terpene, is also a useful chiral synthon and has been 
used in the total synthesis of taxol.127 Furthermore this bioactive enone has been 
reported as an inhibitor of acetylcholine esterase and hence has potential for the 
treatment of early stage Alzheimer’s disease.128 Also this fine chemical is utilised in 
perfumery, aromatherapy and herbal remedies.129 
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1.6 Aim of the project 
 
In view of the importance of (+)-α-pinene and verbenone, the aim of this project was to 
use (+)-α-pinene synthase as a pilot synthetic platform to produce verbenone. The 
project was divided into two parts. The first part is dedicated to heterologous 
expression, purification and characterization of recombinant (+)-α-pinene synthase. 
Several expression conditions and many purification methods were tried in order to get 
optimum results. Furthering the understanding of the protein, i.e. examination of the 
potential catalytic role of several aromatic amino acids in stabilizing the carbocationic 
intermediates generated in the active site of (+)-α-pinene synthase during the natural 
conversion of GDP (4) through site directed mutagenesis was planned.  
 
Once (+)-α-pinene synthase was fully optimized, a chemoenzymatic synthesis of (+)-
verbenone (13) from GDP (4) using the enzyme as the essential biocatalyst was 
described. In addition to this, synthesis of some chemically modified GDP analogues to 
obtain (+)-α-pinene analogues using (+)-α-pinene synthase was also intended. These 
(+)-α-pinene analogues were postulated to display, for practical purposes, enhanced 
biological activities due to potential improvements in their physical properties (e.g. 
potency and stability). 
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CHAPTER 2 
 
 
Heterologous expression, purification and 
characterization of recombinant  
(+)-α-pinene synthase 
 
 
 
 
 
 
 
 
 
 
 
 
	   31	  
 
 
 
2.1 Introduction 	  
The purification of plant mono- and diterpene synthases from their native hosts has 
been shown to be complicated due to difficulties arising from solubility and activity 
issues.130,131 Synthase activity in crude extracts are significantly reduced due to the low 
abundance of these proteins in plant tissue and the presence of large amounts of 
interfering oils, resins and high levels of competing activities.130,131 Plants utilize 
specialized tissues (e.g. glandular trichomes) to synthesise mono- and diterpenes,132  and 
restrict production to certain developmental stages,133 or short periods of transient 
defense reactions,134 which makes the expression highly up-regulated. To overcome 
these complications, many plant terpene synthases are currently identified, cloned and 
heterologously overexpressed in microbes.76 
 
Even though, operationally soluble enzymes localized in plastids such as mono- and 
diterpene plant synthases are notorious for the difficulties associated with their 
purification in the lab. Monoterpene synthases are difficult to solubilize and activate 
because they have, as opposed to cytosolic sesquiterpene synthases, an N-terminal 
plastid targeting polypeptide that, in vivo, is precisely cut upon maturation. In vitro, this 
“cut” is done by empirical truncation of the N-terminal domain; several cuts 
(truncation) are often necessary to produce pseudomature soluble mono- or diterpene 
synthases. This lack of precision greatly affects the heterologous expression and 
purification of plant monoterpene proteins (e.g. APS). The N-terminal transit peptides 
of plant synthases are believed to target the plastids for proteolytic processing to the 
mature forms. Because of this self-association and tight binding to host chaperones 
many mono and diterpene synthases are translated as preproteins.135 Expecting that 
purification issues were likely to arise with APS, the plant gene was first codon 
optimised for expression in E. coli. Codon optimization can alter both naturally 
occurring and recombinant gene sequences to achieve the highest possible levels of 
productivity in any given expression system by increasing the translational efficiency.  
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However, after gene design and expression, APS was obtained as inactive inclusion 
bodies and several protein purification techniques were needed in order to get soluble, 
catalytically active APS. Previous successfully used purification protocols for 
monoterpenes synthases include, ion exchange chromatography, ammonium sulphate 
precipitation, hydrophobic interaction chromatography, size exclusion chromatography 
and affinity chromatography.88,136-138 Although His-tagged terpene synthases are 
catalytically active when expressed, such fusions are, in some cases, inappropriate for 
detailed crystallographic studies.88,137-139  Therefore before introducing a His-tag into 
APS, several different purification protocols were attempted with this particular 
synthase. 
 
2.2 Transformation and purification of the cDNA of α-pinene synthase 
(APS) 
 
A synthetic gene (EpochBioLabs) codon optimised for expression in E. coli encoding 
the monoterpene α-pinene synthase from Pinus taeda (loblolly pine: EMBL/GeneBank 
accession No. AF543530),15 was cloned into the expression vector pET 21d between the 
NcoI and BamHI restriction sites by PCR amplification and ligation as described in 
previous work by the Allemann group.71,72 After expression in E. coli XL1-Blue cells 
and DNA purification, the correct insertion (direction of translation) of the transit DNA 
fragment was verified by sequencing. The purity and molecular weight of this cDNA 
was estimated by agarose gel electrophoresis (Figure 2.1). To confirm the size of cDNA 
more accurately (Figure 2.2), the cDNA synthesized by E. coli (above) was digested 
with the restriction enzyme BamHI to afford a linear DNA (≈ 7.1 kb) that was also 
analysed by electrophoresis in agarose using a different marker. The purified cDNA 
was then sent for sequencing with positive results.  
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Figure 2.1:	  An image of the agarose gel of the cDNA used for expression of the APS gene. Lane 1-2: 
APS cDNA samples. Lane 3: DNA Ladder.	  	  
 
 
 
 
Figure 2.2: Agarose gel analysis of cDNA and linear DNA containing the APS gene. Lane 1: DNA 
digested with BamHI (≈ 7.1 kb). Lane 2: cDNA (≈ 5.6 kb). Lane 3: DNA ladder. 
 
 
2.3 Heterologous (large) expression of APS in E. coli 
 
For protein expression in the present case, the E. coli BL21 (DE3) strain was used with 
bacterial fermentation at 37 °C. A single colony was selected and used to inoculate 100 
mL of LB medium containing ampicillin (LB-amp) at a final concentration of 0.1 
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mg/mL. The culture was incubated overnight at 37 °C, with shaking at 150 rpm. Each of 
6 x 500 mL of sterile LB-amp medium was inoculated with a portion (5 mL) of the 
overnight culture. Cells were incubated at 37 °C with shaking at 150 rpm until the 
optical density (measured at 600 nm, reached 0.5-0.8 units). Each culture was 
independently induced for protein expression by the addition of IPTG (0.5 mM) at 37 
°C. Fermentation was maintained for an additional 3.5 h (37 °C). Cells were harvested 
by centrifugation in a Sorvall RC5C Plus centrifuge (Thermo Fisher scientific, USA) 
(6000 x g RCF, 15 min) using SLA-3000 rotor. The supernatant solution was discarded 
and the pellets of E. coli containing the over expressed enzyme were resuspended in cell 
lysis buffer. The resuspended cells were lysed by sonication on an ice bath and the cell 
lysate was clarified by centrifugation at 5 °C (17000 x g RCF, 30 min). Unfortunately, 
this exploratory protocol yielded only small amounts of the desired soluble protein, and 
most of the APS required extraction from inclusion bodies (Figure 2.3).  
 
Therefore a variety of cell strains and expression conditions were tested to achieve 
efficient production of APS. Culture incubation was carried out at 37 °C for 3.5 h or at 
16 °C for 18 h. The following E. coli strains were used - BL21(DE3), BL21(DE3) 
pLysS, BL21-Codon Plus-(DE3)-RIL and BL21-Codon Plus-(DE3)-RP. 
  
	  	  
Figure 2.3: SDS-polyacrylamide gel analysis of the initial attempt at production of APS from E. coli 
BL21 (DE3) cells. Lane 1: Protein Marker. Lane 2: pellet after base extraction. Lane 3: supernatant 
solution after base extraction. 
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Codon Plus cells contain extra copies of tRNA genes (AGA and AGG for R, AUA for I, 
CUA for L and CCC for P) that are not usually expressed in E. coli but are used in other 
organisms such as plants. Indeed, the best results were obtained using E. coli BL21-
Codon Plus-(DE3)-RIL cells with expression at 16 °C for 18 h. This strain rescues 
expression of proteins originating from plants with AT rich genomes.140 
 
2.4 Isolation of Recombinant APS 
 
After a large-scale APS expression using E. coli BL21-Codon Plus-(DE3)-RIL cells 
with protein induction (IPTG (0.5 mM)) at 16 °C for 18 h as described above, the cells 
were harvested by centrifugation (6000 g, 15 min, 4 °C) and lysed by sonication at 0 °C. 
Protein analysis by SDS PAGE indicated that APS readily aggregated and was found, 
for the most part, as inclusion bodies. In order to solubilise APS, a previously 
developed methodology for microbial sesquiterpene synthases was employed. Briefly, 
the pellet was re-suspended in cell lysis buffer (Tris-base (50 mM), EDTA (5 mM), β-
mercaptoethanol (5 mM) and 100 mL glycerol (10% v/v), pH 8.0.) and the pH of the 
resulting milky suspension was then increased to 12.0 by drop-wise addition of NaOH 
(5 M) at 4 °C. After protein denaturation (i.e. clarification), the basic solution was 
stirred for 30 min at 4 °C. Refolding was then achieved by neutralization (pH = 8) with 
slow addition of HCl (1 M) and stirring (30 min) at 4 °C. The suspension containing the 
solubilised protein was centrifuged (17000 g, 30 min, 4 °C). This efficient and standard 
protocol has been used to extract microbial sesquiterpene synthases from similar 
inclusion bodies extensively. As shown by the SDS-polyacrylamide gel in Figure 2.4 
almost all of the required protein was found in the supernatant solution after 
centrifugation. 
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Figure 2.4: SDS-polyacrylamide gel of APS from E. coli BL21-Codon Plus-(DE3)-RIL cells using the 
optimum growth conditions. Lane 1: Protein Marker. Lane 2: supernatant solution after base extraction. 
Lane 3: pellet after base extraction. 
 
 
2.5 Enzyme Purification 
 
After the successful production of soluble APS, it was then necessary to purify APS to 
carry out its biochemical characterization and further explore to possibly of getting α-
pinene synthase crystals for x-ray crystallographic studies.  Unless otherwise stated, 
Fast Protein Liquid Chromatography (FPLC) was used to purify APS. 
 
2.5.1 Ion exchange chromatography 	  
Initially several attempts to purify α-pinene synthase (APS) were carried out by 
variation of solution pH using ion exchange resins as the stationary phases. Ion 
exchange chromatography (IEC) is based on the difference in the strength of the 
interaction between a sample and the oppositely charged solid support. Elution is often 
accomplished by increasing salt concentration in the eluent over time. Both positively 
charged and negatively charged resins are commercially available. Resource Q and Q-
Sepharose are positively charged and are therefore strong anion exchangers due to the 
presence of quaternary ammonium group on the solid support. Diethylaminoethyl 
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(DEAE)-sepharose is also positively charged but relatively weaker as an anion 
exchanger; it contains an ionisable tertiary amine group on the solid support. Resource 
S and SP-Sepharose are negatively charged, and hence are used as cation exchangers. 
The charged groups of SP-Sepharose and Resource S are sulfonate ions on the solid 
support. 
  
For purification of APS, a DEAE-sepharose column was used in the first trial. Since the 
theoretical pI of the protein is 5.86 (ExPASy-SIB Bioinformatics Resource Portal; 
compute pI/Mw tool), it should be negatively charged at pH 8.3 and hence should bind 
to a positively charge resin such us DEAE-sepharose. However only a small portion of 
the protein bound to the resin. The majority, as indicated by SDS-polyacrylamide gel 
(Figure 2.5), was found in the unbound flow-through solution. 
 
 
	  	  
Figure 2.5: SDS-polyacrylamide gel of APS from E. coli BL21- Codon Plus-(DE3)–RIL cells using the 
optimum growth conditions. Lane 1,2: DEAE-sepharose eluate. Lane 3,4: DEAE-sepharose flow-through. 
Lane 5: Supernatant solution after base extraction. Lane 6: pellet after base extraction. Lane 7: Protein 
Markers. 
 
 
From the predicted pI of APS the positively charged Q sepharose resin (vide supra) 
should be better suited. This resin was explored in small-scale purification experiments, 
along with the negatively charged SP sepharose as a control. 
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In addition, since the initial DEAE sepharose purification attempt was partially 
successful, this resin was tried again on a small scale. On the expectation that better 
results might be obtained by allowing protein sample and resin to equilibrate slowly for 
a longer period of time, the following procedure was followed. Briefly, a few grams of 
each resin, previously equilibrated with cell lysis buffer was placed in separate 
Eppendorf™ tubes followed by addition of cell lysis buffer solution (500 µL) 
containing the crude solubilized APS from inclusion bodies. Gentle mixing by simply 
inverting the Eppendorf™ tube was maintained for 10 min. The mixture was then 
centrifuged for 1 min at 17,000 g and the flow through solution decanted. Cell lysis 
buffer containing 1 M NaCl was added to the resulting pellet and both phases were 
mixed gently to extract any possible bound protein. After centrifugation in a benchtop 
cerntrifuge (1 min at 17,000 g), the flow through solution again was decanted. After 
freeze-drying both supernatant solutions were re-dissolved in 20 mL of cell lysis buffer 
and analysed by SDS-PAGE (Figure 2.6).  
 
	  	  
Figure 2.6: SDS-polyacrylamide gel of the flow through solution (supernatant 2) and eluate from the 
DEAE-sepharose, Q-sepharose, and SP-sepharose ion exchange columns. Lane 1: Q-sepharose eluate. 
Lane 2: Q-sepharose flow-through. Lane 3: DEAE eluate. Lane 4: DEAE flow-through. Lane 5: SP-
sepharose flow-through. Lane 6: SP-sepharose eluate. 
 
 
Unfortunately in both the DEAE and Q-sepharose experiments nearly 97% of the 
protein was found in supernatant, thus only 3% of the APS interacted with these resins. 
For SP sepharose, no visible band corresponding to APS was found in the SDS-PAGE 
analysis (Figure 2.6) of supernatant 2 indicating that in this case the protein did not bind 
at all. Percentages were estimated from relative band intensities using SDS-PAGE. 
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Finally, a DEAE resin drip column left for rotation at cold room temperature for 3 h and 
then the usual drip column purification was carried out as stated below, hoping that 
these conditions will secure a better protein-resin binding and hence better separation. 
The drip column (1.5 × 1.5 cm) was eluted using a stepwise NaCl gradient (0.2-1.0 M)).  
About four column volumes (CV) in 2 mL fractions at each NaCl concentration step 
were collected. All fractions were analysed by measuring their absorbance at 280 nm 
(Figure 2.7).  
     
         
	  	  
Figure 2.7: A) Absorbance profile from the DEAE sepharose elution. B) SDS-polyacrylamide gel of the 
eluate from the same DEAE sepharose column. Lane 1: Protein marker. Lane 2: supernatant solution after 
base extraction. Lane 3: Flow-through solution. Lane 4: fraction 25. Lane 5: fraction 15. Lane 6: fraction 
34. Lane 7: fraction 35 
 
A 
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Two additional ion exchange drip columns charged with either Resource S (6 mL) or 
Resource Q (8 mL) were also tested as means of APS purification. These columns were, 
after equilibration, loaded with Tris buffer (20 mM Tris base, 5 mM EDTA, 5 mM 
βME, pH 7.0) solutions of APS, and eluted with the same loading buffer supplemented 
with 1 M NaCl. Again, no positive results were obtained. All protein eluted with the 
initial loading, unsalted buffer (i.e. in the flow-through solution, Figure 2.8). 
 
	  	  
Figure 2.8: Elution profile from a Resource S column for the supernatant solution after base extraction. 
 
 
 
2.5.2 Ammonium sulphate precipitation 
 
Ammonium sulphate precipitation is an alternative method used to purify proteins.141 
This methodology is based on previous observations showing that protein aggregation 
might be overcome at high salt concentrations due to neutralization of charges at their 
solvent exposed surfaces Thus, this protocol might constitute, in some cases, a simple 
means of fractionating proteins. Charge neutralization means that proteins will tend to 
bind together, form large complexes and precipitate out of the solution, allowing 
collection by centrifugation. Since each protein will start to aggregate at a characteristic 
salt concentration, this approach provides a simple way of enriching a particular soluble 
protein from a mixture. Furthermore the tendency of different proteins in the lysate to 
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aggregate differs as a function of ammonium sulfate concentration, proteins are 
separated in distinct fractions.  
 
 In the present case, the percentage of ammonium sulfate saturation was increased 
stepwise from 10% to 90% adding powdered ammonium sulphate to the crude enzyme 
solution, and stirring for 1 h after each addition.142 Unfortunately, after adding 60% 
ammonium sulphate, APS precipitated along with nearly all the other E. coli proteins 
present, obtained after sonication. This method did not improve the purity of APS as 
shown in Figure 2.9. 
 
	  
Figure 2.9: SDS-PAGE analysis of various ammonium sulphate precipitates from the base extracted 
crude cell lysate. Lane 1: protein marker. Lane 2: 20% saturated. Lane 3: 30% saturated. Lane 4: 40% 
saturated. Lane 5: 50% saturated. Lane 6: 60% saturated. Lane 7: 70% saturated. Lane 8: 80% saturated. 
 
 
 
2.5.3 Hydrophobic interaction chromatography (HIC) 
 
Hydrophobic Interaction Chromatography135 (HIC) is a separation technique that uses 
the physical property of hydrophobicity to separate proteins from one another. In this 
type of separation/purification, hydrophobic hydrocarbon groups (e.g. phenyl, octyl, or 
butyl) form the contact surface of the stationary column to allow interactions with the 
exposed surface of a well-folded protein. As a result, proteins passing through the 
column that have hydrophobic residues on their surfaces elute more slowly, and 
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separate from those that do not. To secure this protein-resin non-covalent interaction, a 
buffer with a high ionic strength is initially applied to the column. The high salt content 
of the buffer reduces the solvation of the protein sample, thus as solvation decreases, the 
exposed hydrophobic regions of the protein are adsorbed, resulting in retention of the 
enzyme. Then, as the salt concentration is gradually decreased elution occurs in order of 
increasing hydrophobicity. 
 
Various 1 mL HIC columns of different media were tested to purify APS (materials and 
methods). Briefly, after equilibration with start buffer (50 mM sodium phosphate buffer, 
1 M NaCl, pH 7.0), the HIC column was loaded with a solution of the protein in starting 
buffer. Proteins were eluted with a decreasing NaCl gradient (1 M to 0 M) in 15 column 
volumes using a flow rate of 1 mL/min. 1 mL fractions were collected. Unfortunately, 
as exemplified in Figure 2.10 for the Hi Trap phenyl HP column, protein did not bind to 
any of the employed HIC columns, and eluted only 2 minutes after loading.  
 
 
 
Figure 2.10: Elution profile of APS using a Hi Trap phenyl HP column. All protein eluted 2 minutes 
after loading to the column. 
 
 
2.5.4 Size exclusion chromatography 
 
To separate molecules of different molecular weights, size exclusion 
chromatography94,143 (SEC) uses stationary materials (resins) harbouring porous 
particles/materials. Thus, molecules that are smaller than the pore size of the resin will 
enter the particles and remain in the column. The average residence time of the particles 
depends mostly on size, but the shape of the analyte is also important. In contrast, larger 
molecules, will elute as part of the flow-through, or void volume. Different molecules 
therefore have different total transit times through the column. Molecules that are 
smaller than the pore size can enter all pores, and have the longest residence time on the 
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column and elute together as the last peak in the chromatogram. This last peak in the 
chromatogram determines the total permeation limit. 
 
For the present APS protein, size exclusion chromatography (SEC) was performed on a 
Superdex-200 (330 mL) column. This column was selected over Superdex-75 (330 mL) 
because the MW of APS13 (65000) is close to the upper limit of the latter (i.e. Superdex-
75 work best for proteins with MW of 3000-70000 and Superdex-200 best for proteins 
with MW of 10000-600000) range.  Although most of APS (95%) eluted at the void 
volume and as an aggregate, it was possible to get 90% pure protein as aggregate 
(Figure 2.11). when Tris buffer (20 mM Tris, 5 mM EDTA, 5 mM βME and 0.15 M 
NaCl at pH 8.0) was used at a constant flow rate of 2 mL/min.  
  
A 
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Figure 2.11: A: Elution profile of the base extracted APS solution from a Superdex 200 SEC column. B: 
SDS-polyacrylamide gel of the flow through solution and eluate from the Superdex 200 column. Lane 1: 
Protein marker. Lane 2: fraction A11 (aggregate peak). Lane 3: fraction B8. Lane 4: crude protein. Lane 
5: fraction B5. Lane 6: fraction C1.  
 
 
Following this preliminary result, different concentrations of crude protein were used to 
reduce aggregation prior elution from the SEC column. Unfortunately, dilution of the 
protein up to x 5 or the use of detergents such us 0.1% (v/v Tween 20 detergent did not 
substantially improve the amount of purified protein isolated (Figure 2.12). 
 
	  
	  
Figure 2.12: SDS-polyacrylamide gel of the flow through solution and eluate from the Superdex 200 
column. Lane 1: protein marker. Lane 2: crude protein (no dilution). Lane 3: Fraction A11 (no dilution). 
Lane 4: Fraction B8 (no dilution). Lane 5: crude protein (2x dilution). Lane 6: fraction A11 (2x dilution). 
Lane 7: fraction B8 (2x dilution). Lane 8: crude protein (5x dilution).  Lane 9: fraction A11 (5x dilution). 
Lane 10: fraction B10 (5x dilution).  
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2.5.5 Affinity Column Chromatography 
 
 Insertion of a histidine tag into APS  
 
A widely used method for protein purification is by inserting six histidine residues at 
the N or C terminus of a protein.9,10  This is achieved by DNA engineering. This ‘his-
tag’ will then bind Ni2+ ions specifically and so can be used to separate the his-tagged 
protein from all other proteins. A concern however, is that the presence of the his-tag 
may affect the enzyme activity and so, in addition, it was decided to insert a TEV 
(Tobacco Etch Virus) cleavage site between the APS gene and the N-terminal his-tag. 
Since the expression vector pET 21d, harbouring the APS gene was initially designed to 
possess two stop codons, followed by 18 base pairs, a sequence coding for six histidine 
residues follow by a stop codon, it was straightforward to insert the TEV cleavage site 
by replacing the two stop codons. This DNA manipulation results in the desirable, 
removable tag of 6x histidines at the N-terminus of the protein. 
 
PCR was performed in order to remove the two stop codons and to insert the codons for 
a TEV cleavage site (ENLYFQG) before the his-tag coding region. In the forward 
direction (5’ to 3’) a primer was designed to contain the existing hexa-histidine tag 
codons. In the reverse direction, a primer was designed to match the first 18 base pairs 
of the APS gene (N terminus) followed by a TEV cleavage site over-hang. The target 
plasmid was amplified by PCR and re-circularised using T4 DNA ligase. The expected 
expression vector was confirmed by DNA sequencing (Figure 2.13). 
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atttgccgcgtgtttcattacggctacaaataccgtgacggctttagtgtggcc 
 
I  C  R  V  F  H  Y  G  Y  K  Y  R  D  G  F  S  V  A   
 
agtattgaaattaagaacctggtgacccgcaccgtcgtcgaaaccgtcccactg 
 
S  I  E  I  K  N  L  V  T  R  T  V  V  E  T  V  P  L   
gaaaacctgtattttcagggccaccaccaccaccaccactgagat 
 
E  N  L  Y  F  Q  G  H  H  H  H  H  H  -  D   
 
 
Figure 2.13: Partial DNA sequence of the his-tagged APS (HAPS) gene. Part of the HAPS coding region 
is shown in blue, the TEV cleavage site coding region is shown in red, his-tag in green and stop codon in 
brown. The amino acid sequence that the gene encodes for is shown below the DNA sequence as a one-
letter code. 
 
 
For the final production of His tagged α-pinene synthase protein (HAPS), E. coli BL21 
Codon Plus (DE3) RIL cells were used to express the gene described above.  Thus, 
cultures were grown at 37 °C followed by induction using IPTG (0.5 mM) at 37 °C for 
4 hours as previously described (section 2.3) for APS. The protein was found again as 
inclusion bodies and then solubilised as described in section 2.4 by acid/base treatment. 
Purification of the resulting solution HAPS supernatant 2 using Ni affinity 
chromatography was then attempted. The supernatant 2 obtained after base extraction as 
described in section 2.4 was dialysed against binding buffer (100 mM Tris, 500 mM 
NaCl, 1mM imidazole, and 5 mM βME) and loaded onto a Ni2+ affinity column 
(HisTrap FF Crude, 1 mL column) pre-equilibrated with binding buffer using an AKTA 
FPLC system. Binding buffer (20 column volumes) was then passed through at a flow 
rate of 1 mL/min, and fractions (10 mL) were collected. Protein was eluted at 1 
mL/min/fraction using a 20 to 500 mM gradient of imidazole in binding buffer over 10 
column volumes. Fractions containing HAPS were collected and protein purity was 
assessed using SDS-PAGE (Figure 2.14). 
 
Similarly, the nickel affinity purification of APS was also accomplished using a Ni2+-
SepharoseTM 6 Fast Flow drip column (GE Healthcare, 5 mL) following a procedure 
similar to that described above. In short, after equilibration, and loading, the column 
was washed with binding buffer (10 column volumes) prior to elution of HAPS 
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(approximately at 2-3 mL/min) using a 50 to 500 mM imidazole gradient in binding 
buffer. HAPS eluted at approximately 50-200 mM imidazole as indicated by SDS gel 
(Figure 2.15).  
 
 	   	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.14: A) Elution profile of the base-extracted HAPS solution from a HisTrap FF column. B) SDS-
polyacrylamide gel of the flow through solution and eluate from the Ni2+ affinity chromatography. Lane 
1: crude protein solution. Lane 2: fraction X1. Lane 3: fraction X2. Lane 4: fraction A7. Lane 5: fraction 
A8. Lane 6: fraction B10. Lane 7: protein marker. 
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Figure 2.15: SDS-polyacrylamide gel of the flow through solution and eluate from the Ni2+ sepharose 
drip column. Lane 1: protein marker. Lane 2: crude protein after base extraction. Lane 3: flow-through. 
Lane 4: eluate with 150 mM imidazole. Lane 5: eluate with 200 mM imidazole. 	  	  
Fractions containing protein of the correct molecular weight were pooled and dialyzed 
overnight against storing buffer (10 mM Tris, 5 mM βME, pH 7.5.) HAPS was 
concentrated to a final volume of ~10 mL (AMICON system, YM 30). This YM 30 
ultrafiltration disc is made out of regenerated cellulose and has 30 kDa nominal 
molecular weight limit (NMWL). Typically this membrane is used for desalting or 
alternatively concentrating of proteins. Glycerol (10% total volume) was added and the 
resulting dialysed solution was aliquoted (1 mL) and stored at -20°C. The concentration 
of protein was measured using the Bradford method144 and found to be 40 µM. 	  
2.6 Product profile of purified (+)-HAPS. 
 
The ability of HAPS to produce (+)-α-pinene was assessed on an analytical scale. 
HAPS (20 µM) were incubated with GDP (2.0 mM, 25 µL) in reaction buffer (0.5 mL, 
100 mM Bis-Tris propane, 50 mM KCl and 20 mM MgCl2, pH 7.5). The aqueous layer 
was overlaid with 0.5 mL pentane and sealed to trap enzymatic volatiles produced by 
HAPS. After gentle shaking overnight at room temperature, the organic layer was 
removed and the aqueous layer was extracted with additional pentane (0.5 mL x 2). The 
Mass of 
 HAPS 	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pooled pentane extracts were passed through a short silica gel column (≈ 3 g silica) in a 
Pasteur pipette prior to analysis of products by GC-MS. Injections (10 µL) were 
performed in split mode (split ratio 5:1) at 50 °C. The GC program was as follows: 
initial oven temperature of 49 °C, held for 1 min followed by a ramp of 4 °C min-1 for 
25.25 min to final temp of 150 °C. 
 
The total ion chromatogram (TIC) showed a single major product (m/z 136) (Figure 
2.16), identified as α-pinene by co-elution with an authentic standard from Sigma-
Aldrich. This experiment clearly indicated that the HAPS obtained was catalytically 
active and gave the expected product. Incubations were repeated without enzyme 
(background), and the analysis of volatiles was also done without the silica gel filtration 
step. These experiments revealed the mandatory presence of HAPS for the production 
of α-pinene, and the absence of any enzyme generated C10 alcohol.   
 
 
	  	  
 
Figure 2.16: Total ion chromatogram of the pentane extractable products from incubation of GDP with 
HAPS. The product was identified as (+)-α -pinene by coinjection with an authentic standard (Sigma-
Aldrich). Inset: EI+-mass spectrum of (+)-α -pinene. 
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As had been reported previously,5 in addition to (+)-α-pinene (2) (91%) the 
recombinant enzyme also generated small amounts of camphene, β-pinene , β-myrcene,  
3-carene, limonene and terpinolene and an unidentified monoterpene (98% conversion 
from GDP (Figure 2.17)). The figure was calculated from calibration curves using 
racemic α-pinene (see section 3.3.1 for details). 
 
 
 
	  	  
 
Figure 2.17: Top: Total ion chromatogram of the pentane extractable products derived from incubation 
of GDP with HAPS at two levels of sensitivity. Bottom: Expanded TIC highlighting 6-12 min time span. 
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All products except the peak at 6.71 min were identified by co-elution with authentic 
material and comparison with their mass spectra with those available in the NIST 
(National Institute of Standards and Technology) library. The compound eluting at 6.71 
min was tentatively identified as tricyclene (1,7,7-trimethyltricyclo-[2.2.1.02.6]-heptane, 
based on MS comparisons (Figure 2.18 and 2.19). 
 
 
	  	  
Figure 2.18: Mass spectrum of the compound eluting at 6.71 min in Fig. 2.17. 
 
 
 
 
	  	  
 
Figure 2.19: Head to tail comparison of the mass spectrum of the compound eluting at 6.71 min in Fig. 
2.17 (red) with the mass spectrum of tricyclene from the NIST library (blue). 
	   52	  
2.6.1 Chiral GC analysis of (+)-α-pinene 
 
Gas Chromatography with flame ionisation detector (GC-FID) (Perkin Elmer 8700) 
analysis of the extracts from incubations of GDP and HAPS using a chiral stationary 
phase (Supelco DM beta-Dex L20 column (30 m x 0.25 mm internal diameter) and 
comparisons with an authentic sample of  (±)-α -pinene  (Fig. 2.22) indicated that the 
enzymatic (+)-α-pinene was enantiomerically pure ((>98%).  Chiral GC analyses was 
performed isothermally at 80 °C (Figure 2.20). 
 
	  
Figure 2.20: Red: FID gas chromatogram of commercial (±)-α-pinene passed over a β-cyclodextrin 
stationary phase. Black: (+)-α-pinene generated from incubation of GDP with HAPS.  
 
 
2.7 Optimisation of (+)-APS catalysed production of α-pinene 
 
To evaluate the optimum conditions for large-scale production of (+)-a-pinene by 
HAPS, a fixed concentration of enzyme (10 µM, 25 µL) was first incubated with fixed 
concentration of GDP on an analytical scale at different pH, temperatures, 
concentrations of substrate, cofactors (metals). To determine the optimal enzyme 
concentration, incubations were performed at varying enzyme and fixed GDP 
concentrations. 
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2.7.1 Optimum Mg2+ concentration 
 
For analysis of the optimum Mg2+ concentration, 2mM GDP was used in a 0.5 mL final 
volume. The buffer consisted of Bis-Tris propane (100 mM), KCl (50 mM), MgCl2 and 
DTT (1 mM), pH 7.5). The concentration of Mg2+ ion in the assay buffer was varied 
from 5 mM to 500 mM. Each mixture was overlaid with pentane (0.5 mL) and initiated 
by addition of enzyme (10 µM, 25 µL). After incubation for 16 h the pentane layer was 
removed (as described above, section 2.6), and then analysed by GC-MS. The total ion 
count of the integrated α-pinene peak was used to estimate the quantity of α-pinene 
produced. The optimal Mg2+ ion concentration of α-pinene synthase was found to be 
100 mM (Figure 2.21).  
 
	  	  
 
Figure 2.21: Effect of [Mg2+] on the total ion count for HAPS catalysed production of α-pinene 
 
 
2.7.2 Optimum pH 
 
To find the optimum pH for production of α-pinene, the enzyme was incubated with 
GDP under analytical conditions as stated above (section 2.6.1), varying the pH of the 
buffer from pH 6.0 to 9.5. The optimum Mg2+ (100 mM) concentration was used and 
the enzyme concentration was held constant (10 µM, 25 µL) as before. The optimal pH 
for the production of α-pinene was found to be 7.5 (Figure 2.22). 
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Figure 2.22: Effect of pH on the total ion count for HAPS catalysed production of α-pinene 
 
 
 
2.7.3 Optimum temperature 
 
To find out the optimum temperature for HAPS catalysis several runs were carried out 
under identical conditions. The optimum temperature for the enzyme activity was found 
to be 20 °C (Figure 2.23). 
 
	  	  
Figure 2.23: Effect of temperature for HAPS catalysed production of α-pinene. 
 
 
 
Thus the best buffer solution and incubation conditions for the production of α-pinene 
were found to be Bis-Tris propane (100 mM), KCl (50 mM), MgCl2 (100 mM) and DTT 
(1 mM), pH 7.5 at 20 °C. 
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2.8 Kinetic studies 
 
The kinetic evaluation (KM and kcat) of HAPS was carried out using radiolabelled [1-3H 
(specific activity 20 Ci/mmol)]-GDP under optimised reaction conditions (vide supra). 
As a start, the incubations were performed using 1 µM HAPS with 10 µM of [1-3H] 
GDP in a buffer containing 100 mM Bis-Tris propane, pH 7.5, 50 mM KCl and 10 mM 
MgCl2 and 1 mM DTT. 
 
2.8.1 Time optimisation 
 
Incubations were performed using different times (5 to 30 min) (for details see section 
3.3.2). A reaction time of 20 min was chosen based on the linearity of the plot shown 
below (Figure 3.24).  
 
	  	  
Figure 2.24: Time course for the production of pentane extractable products from incubation of  
[1-3H]-GDP with HAPS. 
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2.8.2 Enzyme concentration optimisation 
 
In this case, reactions (20 min) were performed at variable enzyme concentration (0 - 5 
µM) using the aforementioned buffer solution (Figure 2.25). 
 
	  	  
Figure 2.25: Plot of  [HAPS] versus radioactivity (in DPM) for the formation of radiolabelled pentane 
extractable products after 20 min incubations of [1-3H]-GDP with HAPS. 
 
 
A concentration of 0.4 µM HAPS was defined as the optimal one from the initial linear 
range. Some terpene synthases have a tendency to aggregate at high concentrations 
leading to lower activity of the enzyme. This low concentration (0.4 µM HAPS) of 
HAPS (Figure 2.25) was selected to guarantee that no aggregation of the enzyme would 
occur, ensuring the necessary Michaelis-Menten conditions (rate proportional to [E]) 
needed for kinetic measurements. 
 
2.8.3 Magnesium concentration optimisation 
 
Using 0.4 µM of enzyme in buffer (100 mM Bis-Tris propane, pH 7.5, 50 mM KCl and 
1mM DTT for 20 min (Figure 2.26) at different Mg2+ concentrations (5 µM to 50 µM), 
a concentration of 20 µM for Mg2+ was determined as optimal. 
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Figure 2.26: Plot of [Mg2+] versus reaction velocity for the formation of radiolabelled pentane extractable 
products after 20 min incubations of [1-3H]-GDP with HAPS 
 
2.8.4 Temperature optimisation 
 
To assess the optimal incubation temperature needed, reactions were performed at 
variable temperatures (10 to 45 °C) in a buffer containing 0.4 µM of enzyme, 20 mM 
Mg2+, 100 mM Bis-Tris propane, pH 7.5, 50 mM KCl and 1mM DTT for 20 min 
(Figure 2.27). 
 
	  
 
Figure 2.27: Plot of temperature versus reaction velocity for the formation of radiolabelled pentane 
extractable products after 20 min incubations of [1-3H]-GDP with HAPS 
 
A temperature of 25 °C was defined as the optimal temperature as it gives the best 
activity within a reasonable amount of time.  
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2.8.5 Determination of kinetic parameters for HAPS 
 
The steady state kinetic parameters KM and kcat were determined using the optimised 
conditions described above (0.4 µM of enzyme, 20 mM Mg2+, 25 °C and 20 min). 
Kinetic assays were performed using a variable concentration of [1-3H] GDP from 10 to 
120 µM (Figure 2.28). 
 
The reaction mixtures containing GDP, protein and buffer were prepared on ice using 
eppendorf vials in a total volume of 250 mL and overlaid with 1 mL of HPLC-grade 
hexane prior incubation at 20 °C with shaking for 20 min. The reactions were then 
immediately ice-cooled and quenched by addition of 200 µL of a 100 mM EDTA 
solution (pH 8.5) and briefly vortexing. The hexane overlay and two additional 1 mL 
hexane extracts were passed through a short pipette column containing silica gel. The 
column was washed with an additional 1 mL of hexane, and the combined filtrates were 
analysed by liquid scintillation counting using 15 mL of scintillation cocktail. Steady-
state kinetic parameters for wild-type HAPS were obtained by Michaelis-Menten 
equation (V = (Vmax [S]) / (KM + [S])) using the graphical procedures developed by 
Lineweaver-Burk145,146  using the commercial SigmaPlot package (Systat Software). 
	  
Figure 2.28: Michaelis-Menten profile for HAPS, incubating 0.4 µM HAPS with different concentrations 
of [1-3H] GDP. 
 
Based on three individual kinetic runs, the KM value was found to be 40 ± 8 µM, and the 
kcat value 0.001 ± 0.0004 s-1. The KM value is in good agreement with those previously 
reported.15 The N-terminal hexa-histidine tag did not appear to affect the activity of the 
enzyme and all further experiments were performed with HAPS. 
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CHAPTER 3 
 
Chemoenzymatic synthesis of the alarm 
pheromone (+)-verbenone from geranyl 
diphosphate (GDP) 
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3.1 Introduction 
 
Semiochemicals can be defined as chemicals emitted by living organisms that provoke a 
behavioral or physiological reaction in other individuals. They can be classified as 
pheromones or allelochemicals based on how they are used and who gains advantage 
from them.147 Semiochemicals such as phenolics, terpenoids and alkaloids have been 
exploited for their antimicrobial and insect–behaviour–modifying properties.148 Volatile 
terpenoids are known to be involved in direct or indirect defense to attract or repel 
predators.149,150 They are available in relatively large amounts as resins, waxes and 
essential oils, and are important renewable resources, providing a range of 
commercially useful products such as solvents, flavorings and fragrances, coatings, 
adhesives and synthetic intermediates.158  The use of semiochemicals are 
environmentally friendly and reduce the utilisation of harmful and expensive 
insecticides and pesticides.151,152 They also reduce negative effects on public health and 
environmental outcomes.153  
 
Outbreaks of bark beetles and their associated fungal infections are major risks for 
conifer populations worldwide, destroying hundreds of acres of valuable trees every 
year.159 In response to threats, conifers secrete various admixtures of defensive 
compounds. However bark beetles overcome the trees’ defenses by mass attack, which 
is ultimately directed by aggregation pheromones emitted by the beetles, and the ability 
to vector phytopathogenic fungi.154 Norway spruce (Picea abies) when attacked by Ips 
typographus beetles uses the monoterpene α-pinene (12) as a cue for host selection. 
Male beetles convert this C10 hydrocarbon into verbenone (13), which then serves as a 
dispersal alarm pheromone to modulate attack density.  
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 Figure 3.1: A. Image of a mountain pine beetle (Dentroctonus ponderosae), B. Dead pine trees in a 
forest as a result of the beetles. 
 
The prospect of generating enzymatically, relatively large quantities of enantiomerically 
pure (+)-α-pinene (12) (98%) from readily available geranyl diphosphate (4) (Chapter 
2), opens the possibility of an alternative and attractive synthesis of (+)-verbenone (13) 
in enantiopure form. This chapter describes the efforts toward the development of an 
enzyme-guided asymmetric synthesis of (+)-verbenone (13) from GDP (4) in a simple 
two-step, one pot transformation. It should be mentioned that though (1R)-­‐(+)-α-pinene 
(12) is commercially available in high enantiomeric excess (97%), the necessity of 
producing α-pinene enzymatically might not appear obvious. However, this pilot 
project was intended mostly as a proof of concept using a relatively simple target, and 
hence accumulate valuable evidence to assess in-depth the suitability of the approach to 
target more complex terpenoids such as artemisinin (17) or gossypol (22). Indeed, a 
chemoenzymatic synthesis of the antimalarial artemisinin (17) is a current endeavour 
within the Allemann group. In the ideal scenario, an in situ and high-yielding 
regiospecific allylic oxidation of the HAPS-generated α-pinene (12) will generate 
verbenone (13) in one step, without the need for purifying reaction intermediates 
(verbenol, 82) (Figure 3.2), or the use of enzymes to further tailor α-pinene.  
 
 
 
 
 
 
 
 
 
B A 
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Figure 3.2: Proposed two-step synthesis of (+)-verbenone (13) from GDP (4). 
 
 
3.2 Existing methods for the conversion of α-pinene to verbenone 
 
Several methods have been previously reported for the conversion of α-pinene (12) to 
verbenone (13). What follows is a summary of previous syntheses.  
 
Air oxidation is able to convert α-pinene (12) into verbenone (13), however because 
this oxidation is very unselective, verbenone (13) is produced only in low to moderate 
yield, after cumbersome purification protocols.155,156 For example, when  molecular 
oxygen is used in combination with a Co(ΙΙ) catalyst such as [Co(4-
methylpyridine)2Br2], verbenone (13) was obtained in only 37% yield after heating for 
6.5 h at 100 °C. The most abundant side products were verbenol (82) and α-pinene 
oxide (83). Other minor products, derived from further rearrangement of the α-pinene 
oxide byproduct, included α-campholene aldehyde (84), trans-pinocarveol (85), trans-
carveol (86), trans-sobrerol (87) and trans-3-pinen-2-ol (88) (Figure 3.3). 
OP2O6-
HAPS
Mg2+
4 12 13
[O]
O
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Figure 3.3: Side products from the α-pinene oxidation with molecular oxygen.156 
 
 
Various homogeneous and heterogeneous catalysts have also been used to effect this 
conversion157,158 including a three step process that uses Pb(OAc)4 followed by base-
catalysed hydrolysis of the product and oxidation of the epimeric verbenol with 
Na2Cr2O7.159  
 
Conversion of 12 to 13 using cell suspension cultures from Psychotria brachyceras and 
Rauvolfia sellowii has been reported,160 thus showing the potential of native plant cell 
suspension cultures in organic synthesis. These protocols give rise initially to the 
precursor of verbenone, the allylic alcohol trans-verbenol, which is futher, but slowly, 
oxidized to verbenone. This microbial-based technology is therefore better suited for the 
preparation of the aggregation pheromone verbenol (Figure. 3.4) in moderate yield 
(56.9-68.5 % after incubation for 10 days). Nevertheless, other oxidized products such 
as trans-pinocarveol, cis-verbenol and myrtenol were inevitably produced as minor 
products. 
 
O2
OCatalyst HO
+ +
O
12 13 82 83
CHO
+ + + +
HO OH
OH
OH OH
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Figure 3.4: Biotransformation of α-pinene carried out by Psychotria brachyceras and Rauvolfia 
sellowii.160 
 
It has been shown previously that α-pinene (12) can be converted to verbenone (13) 
without the need for isolating the precursor verbenol (82).161 This relatively high 
yielding (65%) approach involves the chromium-catalysed t-butyl hydroperoxide 
oxidation of the hydrocarbon (α-pinene, 12) to the enone (verbenone, 13), and hence 
seemed ideal to attempt a total synthesis of 13 starting from GDP (4) with our in-house 
generated HAPS.161 It was speculated that the simplicity and high yield of this 
methodology combined with the compatibility of the reagents with those utilize in 
terpene synthase catalysed reactions (buffer, pH, co-factors…etc) might allow the use 
of an advantageous two-phase system to carry out the enzymatic (4 to 12) and oxidation 
(12 to 13) reactions  in the same flask (Figure 3.5). 
 
 
 	  
 
Figure 3.5:	  Synthesis of (±)-verbenone (13) from (±)-α-pinene (12) 
 
 
OH O
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(-)-α-pinene trans-verbenol (-)-verbenone
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OH O
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3.3 (+)-α-Pinene synthase (HAPS) 
 
By comparison, a chemical total synthesis of α-pinene (12) and then verbenone (13) 
would necessarily require the construction of a complex [3.1.1]-bicyclo ring system 
with control of the stereochemistry at the two bridged centers and the regiospecific 
introduction of a trisubstituted double bond. It is worth mentioning that to date no total 
synthesis of α-pinene exists. In contrast, the Mg2+-dependent enzymatic cyclisation of 
GDP (4) catalysed by HAPS achieves all these complex synthetic tasks in one single 
step.159,162 Thus the combination of this enzymatic reaction with an oxidation catalyst 
such us (Cr(CO)6) might allow a novel chemoenzymatic synthesis of verbenone. 
 
A codon optimised synthetic gene for HAPS from Pinus taeda was inserted into the 
vector pET21d for production of the enzyme in E. coli. To facilitate purification, a 
hexa-histidine tag (His6) and a TEV cleavage site were inserted at the 3’ end of the APS 
coding region. E. coli BL21 (DE3) RIL cells were transformed with the resulting 
plasmid. APS-His6, and enzyme production was induced with IPTG. The resulting 
recombinant α-pinene synthase (HAPS) was purified by Ni2+-affinity chromatography 
(see section 2.5.5 for details). 
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3.3.1 Calibration of α-pinene concentration 
 
In order to estimate the chemical yield (or conversion) of the enzymatic reaction, 
pentane solutions of racemic α-pinene (12) of known concentration (0.1-0.9 mM) were 
prepared as standards, and analysed by GC-MS (conditions as above). The total ion 
counts under the peak corresponding to α-pinene (12) in the TIC were then plotted 
against the concentration of α-pinene (12) to obtain the required calibration curve of α-
pinene (12) (Figure 3.6). 
 
 
 
 
Figure 3.6: Calibration curve for determination of GDP concentration by GC-MS. Graph shows total ion 
counts (average after 2 repeats) for the integrated α-pinene peak versus known concentrations of racemic 
α-pinene (Sigma-Aldrich). 
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3.3.2 Analytical incubation of HAPS with GDP (4) 
 
The ability of HAPS to produce α-pinene (12) was tested using analytical scale 
incubations. In brief, HAPS (20 µM) was incubated with GDP (4) (2.0 mM, 25 µL) in 
incubation buffer (100 mM Bis-Tris propane, pH 7.5, 50 mM KCl and 20 mM MgCl2) 
in a final volume of 0.5 mL. The reaction solution was overlaid with 0.5 mL pentane to 
capture volatiles. After gentle shaking overnight at room temperature, the organic layer 
was removed and the aqueous layer was extracted with additional pentane (0.5 mL). 
The pooled pentane extracts were filtered through silica (≈3 g) and the eluent was 
analyzed by GC-MS. The total ion chromatogram (TIC) showed a single major product 
(m/z 136) (Figure 2.16), which was positively identified as α-pinene (12) by co-elution 
with an authentic standard. Incubations were repeated without enzyme, or without 
filtration to check for possible enzyme derived alcohol products (see section 2.6 for 
details). 
 
These experiments clearly indicate that the enzymatic preparartion of HAPS was 
catalytically functional producing 91% of  the expected monoterpene when incubated 
with GDP (4). 
 
3.4 Synthesis of verbenone from (±)-α-pinene 
  
To develop the planned 2-step, 1 pot synthesis of verbenone from GDP (4), the 
oxidation reaction was extensively optimized through use of different temperatures, 
solvents and equivalents of ButOOH and chromium catalyst relative to the substrate 
racemic α-pinene (12). 
 
As background, the oxidation of racemic α-pinene was carried out first, exactly as 
described by Pearson et al.161 This reaction was conducted on a 2 mmol scale. Thus, to a 
suspension of α-pinene (12) (277 mg, 2.03 mmol) and Cr(CO)6 (224 mg,1.02 mmol) in 
a mixture of CH3CN/benzene (5:1; 6 mL) was added dropwise 70% wt. aqueous 
solution of tBuOOH (0.61 ml, 6.1 mmol). The resulting mixture was heated under 
reflux for 17 h and then cooled in an ice bath. The solids were filtered and washed with 
additional benzene and ether. The resulting organic layer was extracted with 5% NaOH 
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(40 mL), and this basic layer was then back extracted with ether (3 x 20 mL). The 
combined organic extracts were dried (MgSO4), filtered, and the solvent removed under 
reduced pressure. The residue was purified by flash column chromatography on silica 
gel to give racemic verbenone in 68% yield.  
 
Hence, in the presence of chromium hexacarbonyl, t-butyl hydroperoxide causes the 
catalytic oxidation of α-pinene (12) to give verbenone (13). The authors of the above 
described reaction state that when benzene is used as the solvent, small amount of 
epoxides are formed as side products. By changing the solvent to acetonitrile this 
problem was overcome. α-Pinene (12) was not completely soluble in acetonitrile 
therefore a small amount of benzene was used as co-solvent (10:1 ratio).161  Under these 
conditions, the reaction gave 68% yield when α-pinene (12) is refluxed for 18-20 hours. 
The remainder (32%) was starting material. Fortunately, this reaction was also 
successful when carried out on a small scale (2 mM of enzymatically produced (+)-α-
pinene (12) in 1 mL of acetonitrile). 
 
3.5 Development of a protocol towards production of verbenone (13) 
from enzymatically produced α-pinene (12) 
 
The synthesis of verbenone from α-pinene (12) as stated in the section 3.4 required 10:1 
mixture of benzene and acetonitrile as solvent. However, under the standard enzymatic 
incubation conditions (Section 2.6)  α-pinene (12) is extracted from water into pentane, 
thus the ability of different solvents to trap the enzymatic volatiles produced was tested 
on small analytical incubations. Solvent screening through use of GC-MS indicated that 
benzene or CH3CN alone could not be used due to enzymatic inactivation or 
precipitation of GDP (4), HAPS or both, possibly as a consequence of partial mixing 
with the aqueous solution. Similarly toluene and xylene also prevented the enzymatic 
reaction from taking place. 
 
Conveniently, however, the Cr(CO)6 catalysed oxidation of racemic pinene took place 
when  pentane was used as the solvent (Table 1). Nevertheless, the limited solubility of 
Cr(CO)6 in pentane required use of 20 molar equivalents of this reagent. It is known that 
in Cr(CO)6 catalysed oxidation reactions;165 CH3CN acts both as a solvent and as a 
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ligand. Indeed, the addition of small amounts of CH3CN (10% v/v) to pentane led to the 
efficient oxidation of 12 by tBuOOH in the presence of only 2 molar equivalents of 
Cr(CO)6 with a yield of 56%. The slightly lower yield relative to the reaction carried out 
in CH3CN could be attributed to use of pentane as a solvent, which likely reduces the 
stability (and solubility) of the Cr(0) catalyst. Although less efficient than CH3CN in the 
single step reaction, pentane was essential for effective enzyme catalysed conversion of 
4 to 13. In addition, four molar equivalents of tBuOOH relative to the chromium reagent 
were necessary, but otherwise the results were consistent with previous studies 
employing this reaction.161  
 
Surprisingly, after optimization with racemic α-pinene, when this reaction was 
attempted with the HAPS-produced (+)-α-pinene (12), no oxidation reaction was 
observed. It is well known that sulfur can poison metal-based catalysts.164 Thus, it 
seemed possible that the amounts of β-mercaptoethanol (βME) present in the incubation 
buffer might be sufficient to inhibit the subsequent oxidation of pinene (12) to verbenol 
(82)/verbenone (13). This hypothesis was confirmed by carrying out the oxidation 
reaction of racemic α-pinene (12) in the presence of 1 mM βME. When a large excess 
of tBuOOH (15–30 molar equivalents) relative to α-pinene (12) was used, the reaction 
smoothly proceeds to verbenone. Thus the deleterious presence of βME could be 
successfully overcome simply by using an excess of the oxidant.  Alternatively, the 
initial pentane solution containing the HAPS-produced α-pinene could be passed 
through a short column of silica gel to remove βME prior to Cr(CO)6/tBuOOH 
oxidation in a different reaction vessel.  
 
Attempts to overcome the 2-phase reaction design were also made using non-aqueous 
incubations. To this end, aliquots (1 mL) of the stock HAPS solution (4 mM), Mg2+ 
concentration (20 mM) and pH (to 7.5) were adjusted and placed in Eppendorf tubes. 
Tubes were flash frozen by liq. N2 and lyophilized.163 Pentane (1 mL) and GDP (4) (2 
mM) were added to the resulting residue, and the tube was tightly capped and kept at 25 
°C for 12 h with moderate shaking. As a control, 500 µL of the usual aqueous buffer 
containing the same concentration of GDP (4) was added (overlaid with pentane (0.5 
mL) and incubated under the same conditions. After incubation, the pentane layers of 
both experiments were analysed by GC-MS with negative results as (-)-α-pinene was 
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not detected in either case. This control experiment indicated that the enzyme was 
deactivated upon lyophilisation.  
 
Table 1: Results of attempts at optimisation of the solvent system and reagent requirements for the 
chemoenzymatic synthesis of verbenone (13) from GDP (4) 
 
[βME] in aq. 
buffer (mM) Cr(CO)6
a tBuOOHa Organic solvent Yield (%) 
5 — — CH3CN < 1b 
5 — — C6H6 < 1b 
5 — — C6H5CH3 < 1b 
5 — — p-xylene < 1 
5 10 15 n-C5H12 < 3 
5 20 30 n-C5H12 < 3 
0 20 30 n-C5H12 40c 
0 2 8 10% CH3CN in n-C5H12 
50c 
 
a Molar equivalents relative to GDP. b Yield is for α-pinene only, insufficient quantities were isolated for 
the oxidative step to be carried out. c Overall isolated yield of (+)-verbenone (3). As with the oxidation of 
commercial racemic α-pinene the remaining material was mostly unreacted α-pinene, in addition to small 
amounts of unidentified by-products. All the above reactions were carried out at reflux. 
 
 
3.6 Preparative scale synthesis of (+)-verbenone from GDP 
 
After assessing the scope and limitations of the aforementioned 2-step reaction 
sequence to convert GDP (4) into (+)-verbenone (13) using analytical-scale 
experiments, a preparative scale production of the semiochemical was targeted next. 
Thus, a dialyzed solution (4 mL) of HAPS (4 mM) was added to a 1.6 mM solution of 
GDP (4, 16 mg, 40 mmol) in incubation buffer (23 mL). The resulting reaction mixture 
was overlaid with pentane (10 mL), and the reaction vessel was sealed and gently 
shaken for 24 h at room temp. (+)-α-Pinene (12) was obtained in 89% yield from GDP 
(4) as judged by GC-MS comparisons with authentic standards of known concentration 
(Fig 3.6). To the combined pentane extracts (40 mL), containing the enzymatically 
produce pinene  (ca. 4.9 mg, 36 µmol) was added CH3CN (4 mL), tBuOOH (70% wt. 
aqueous solution, 39.8 µL, 0.29 mmol) and Cr(CO)6 (15.8 mg, 72 µmol) followed by 
heating under reflux for 18 h. After purification by normal phase HPLC (Agilent 1100 
series system using a Waters Nova-PAK silica HR (3.9 mm x 300 mm column), using 
1% isopropanol in hexane at 1 mL/min, (+)-verbenone (13) (tR = 8.84 min) was isolated 
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in 50% overall yield and excellent enantiopurity (>98%, [α]D20 =+233.3 dm-1 cm3 g-1, c 
= 0.06 in CHCl3) as judged by GC-MS (Figure 3.7). The slightly lower relative yield 
when compared to the reaction carried out in CH3CN is most likely attributed to the 
reduced stability and solubility of the Cr(0) catalyst in the pentane. Although less 
efficient than CH3CN in the oxidation step, pentane is essential for the effective 
conversion of GDP to α-pinene. Using this methodology a production capacity of 150 
mg L-1 of (+)-verbenone was achieved. 
 
 
 
 
 
Figure 3.7: Total ion chromatogram of chemoenzymatically synthesized (+)-verbenone. Inset: EI+ mass 
spectrum of verbenone. 
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3.7 Chiral GC analysis of (+)-verbenone 
 
(+)-Verbenone was produced in >98% ee as judged by chiral GC comparison with 
racemic and commercial (-)-verbenone (Figure 3.8). Chiral GC analyses were 
performed on a Perkin Elmer 8700 Gas Chromatograph using a Supelco 23404 beta-
Dex L20 column (30 m x 0.25 mm internal diameter) with an FID detector.  
 
 
Figure 3.8: Chiral GC-analysis of chemoenzymatically generated verbenone. (a) racemic verbenone 
generated from racemic pinene using tBuOOH and Cr(CO)6; (b) (-)-verbenone obtained from Sigma-
Aldrich; (c) chemoenzymatically generated (+)-verbenone; (d) racemic verbenone spiked with 
chemoenzymatically generated (+)-verbenone (the peak at tR = 22.79 min is enhanced). 
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3.8 Conclusion 
 
A chemoenzymatic synthesis of (+)-verbenone (13) in 50% yield and >98% optical 
purity was achieved in two steps starting from GDP (4). This method favourably 
compares to previous syntheses as it avoids the isolation of intermediates (α-
pinene/verbenol) and is, for the most part, devoid of undesirable by-products. Although 
verbenone (13) is a cheap commercially available natural product, this method 
constitutes a synthetic platform reference for the chemoenzymatic preparation of other 
valuable fine terpenoids such as artemisinin (17) and artemisinin derivates. 
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CHAPTER 4 
 
Site-directed mutagenesis study of four 
aromatic residues potentially involved 
during catalysis by HAPS 
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4.1 Introduction 
 
Using wild type cDNA as the templates, site-directed mutagenesis (SDM) experiments 
allow the generation of altered DNAs encoding proteins modified at one particular 
position. This method is extremely useful for examining the importance of specific 
residues in protein structure and function. SDM is indeed one of the rational methods 
used in protein engineering to alter the enzyme’s selectivity for its natural substrate as 
well as its function.166,167 More in particular, SDM has become a fundamental chemical 
biology tool to examine the intricate electrophilic pathways mediated by terpene 
synthases, the enzyme’s contributions to catalysis, and to produce enzymes with altered 
specificities. Over time, fundamental mechanistic insights have been inferred simply by 
comparing the kinetic parameters and product profile of a given site-directed mutated 
enzyme with the parent terpene synthase168,169 This powerful approach has also allowed, 
just to name one example relevant to this investigation, engineering of a (-)-camphene 
synthase using the cDNA template of a highly specific (89%)  plant (-)-pinene synthase. 
Nevertheless, despite both wild type synthases having highly homologous amino acid 
sequence and hence very similar three-dimensional structures, several amino acid 
substitutions were necessary to alter the catalysis from (-)-pinene synthase to (-)-
camphene synthase.170 
 
In the present case, SDM was applied to α-pinene synthase (HAPS) to examine the 
potential catalytic role of several aromatic amino acids, in stabilizing the carbocationic 
intermediates generated in the active site of HAPS during the natural conversion of 
GDP (4) to the monoterpene α-pinene (12) (Figure: 4.1), All mutants generated for this 
study were expressed, purified and incubated with GDP as described for wild type 
HAPS. The enzymatic products generated by the HAPS variants were analyzed by GC-
MS, and kinetics parameters with radiolabelled GDP (4) were determined as described 
previously for the parent monoterpene synthase.  
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Figure 4.1: Proposed mechanism for the HAPS catalysed conversion of GDP (4) to α-pinene (12)  
 
 
4.2 Homology model of HAPS 
 
Several X-ray crystal structures of class I terpene synthases have been solved to date, 
including three plant monoterpene synthases.88,92,171 These structural studies have 
shown that, in general, the active sites of terpene synthase are lined with aromatic 
amino acid residues.172,173 Indeed, the presence of these large hydrocarbon residues 
appears ideal to provide the hydrophobic and desolvated environment needed to secure 
the stabilization, (e.g. by cation π-interaction) of the carbocation generated after 
diphosphate ionization and propagation of the cationic reaction cascade.72,73,174,175,176 
 
Although no X-ray crystallographic data is available for HAPS, it was possible to 
construct a structural homology model of HAPS based on the crystallographic 
coordinates of limonene synthase from Mentha spicata as it gave the best fit for the 
model of HAPS.92 The crystal structure of limonene synthase co-crystalized with the 
substrate analogue 2-fluorogeranyl diphosphate (2ONG.pdb) was used to model the 
structure of HAPS and the fluorinated ligand was preserved. The structural model was 
constructed through the automated comparative protein modeling server I-Tasser177 and 
visualized with the program VMD178 (Figure 4.2). 
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Figure 4.2: Homology model of HAPS with 2-fluorogeranyldiphosphate (2F-GDP - purple) docked at the 
active site. (A) Active site residues F480, F597, Y601 and F607 targeted for site directed mutagenesis. 
(B) Another stereo view of active site residues with F597, Y601 and F607. 
 
 
4.3   Selection of potential carbocation stabilising amino residues 
 
Based on the homology model of HAPS tyrosine (Tyr) 601 and phenylalanines (Phe) 
607, 597 and 480 are residues in the proximity of the ligand, 2F-GPP, and hence they 
could be involved in stabilising nearby carbocationic intermediates via cation- π 
interactions72,73,174,175,176  (Figure 4.1).  According to the above model, F597, Y601 and 
F607 could be involved in stabilisation of the 4S-α-terpinyl cation (79) since they are 
F480 
F597 
Y601
24 F607 
2F-GDP 	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poised close to the distal double bond of the ligand 2F-GDP. Also since F480 is 
predicted to be located towards the head of the substrate, it could stabilize the initial 
geranyl and linalyl carbocations formed after loss of pyrophosphate ion (Fig. 4.1). 
 
In this chapter the catalytic roles of these aromatic residues were evaluated by SDM 
using residues of different size (Ala), electrostatic properties (Ala, and Leu) and 
hydrogen bonding capabilities (Tyr). Substitutions of aromatic residues by alanine often 
result in drastic catalytic changes due to the lost of both the aromaticity and steric bulk. 
Replacement by Leu will preserve (approximately) the size of the residue but the 
electrostatic effects (π-stabilisation) of an aromatic ring will be lost. Finally Tyr, an 
aromatic residue that could be involved in hydrogen bonding networks with other 
residues, or with bulk solvent, and hence substantially change the original active 
environment of HAPS, upon replacing the natural Phe residues. To this end a series of 
primers were designed to alter the selected codons in the gene encoding in polymerase 
chain reactions (PCR) using Pfu polymerase (Materials and methods). The native and 
mutated codons for each of the selected residues are listed below (Table 4.1).  
 
Table 4.1: Comparison of native codons from HAPS with mutated codons. 
 
 
 Y601A Y601F Y601L F607A F607Y F607L 
Native 
codon 
  TAC   TAC   TAC   TTT   TTT   TTT 
Substituted 
codon 
  GCG   TTT   CTG   GCG   TAT   CTG 
 
F480A F480Y F480L F597A F597Y F597L 
  TTT   TTT   TTT   TTT   TTT   TTT 
  GCG   TAT   CTG   GCG   TAT   CTG 
 
 
A total of 12 cDNAs were produced and over-expressed in E.coli. Briefly, the 
methylated parent DNA was digested by Dpn1 restriction enzyme after PCR 
amplification to remove all parental DNA. XL1-Blue super competent cells were then 
transformed with the Dpn1 treated mutated plasmid solution. After transformation, the 
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mutated plasmids were purified by miniprep and gene sequences were confirmed by 
DNA sequence analysis. Preparative-scale and active preparations of these HAPS 
mutants were performed exactly as described for the parent enzyme. The functional 
analysis of the resulting HAPS variants was carried out through GC/MS analysis of 
pentane extractable products from incubations with GDS as previously indicated for the 
parent enzymes, the results are shown in Table 4.2. The kinetic parameters were 
measured using the radioactive assay146 (See section 2.7.5 for details) and the results are 
shown in Table 4.3. However, the kinetic parameters of HAPS-F597L and HAPS-
F480L were extremely difficult to measure with confidence. 
 
 
Table 4.2: GC results of mutant HAPS incubation with GDP 	  	  
Mutant Products (GC-MS) 
Y601A/L/F (Inactive) 
F607A (Inactive) 
F607L/Y α-pinene 
F480A (Inactive) 
F480L/Y α-pinene 
F597A (Inactive) 
F597L/Y α-pinene 
 
 
  Table 4.3: Kinetics parameters of HAPS mutants.   
 
  Protein KM (µM)   kcat (s-1)    kcat/KM (M
-1s-1) 
  WT 40.0 ± 8.0 0.00100 ± 0.00040    25 ± 
 
11 
  F607L 86.5 ± 32.8 0.00020 ± 0.00004   2.4 ± 1.0 
  F607Y 133.2 ± 31.9 0.00018 ± 0.00001   1.4 ± 0.3 
  F597Y 138.8 ± 33.7 0.00082 ± 0.00001   5.7 ± 0.6 
  F480Y 80.3 ± 26.1 0.00016 ± 0.00002   2.0 ± 0.7 
 
 
 
 
	   80	  
 
 
 
Figure 4.3: Michaelis-Menten profile for HAPS-F607L 
 
 
 
 
 
 
 
Figure 4.4: Michaelis-Menten profile for HAPS-F607Y 
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Figure 4.5: Michaelis-Menten profile for HAPS-F480Y  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6: Michaelis-Menten profile for HAPS-F597Y  
 
 
 Only 6 variants out of 12 (Table 4.2) were active, and interestingly they all produce α-
pinene as the exclusive enzymatic product. Indeed, taking into account the chemical 
complexity of the reaction catalyzed by HAPS (at least 4 carbocations are involved), it 
is remarkable that the specificity of the WT enzyme is preserved in the mutants. From 
the results shown in Table 4.2, it is evident that the replacement of these aromatic 
amino acids by alanine precludes binding the substrate, or reactions the initial 
diphosphate ionisation. With the exception of Y601, substitutions by the bulkier leucine 
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led to active HAPS. Nevertheless, the kinetics parameters of HAPS-F607L clearly 
indicate that this mutation is catalytically deleterious causing a 5-fold decrease in the 
reaction rate constant (kcat).   
 
4.4 Conclusion  
 
In conclusion, these 4 aromatic residues are important for the enzyme’s function as 
replacement to each residue making the enzyme less reactive respect to WT enzyme.  
The replacement by a residue of different electrostatic and hydrogen bonding properties 
drastically change either the HAPS structure (folding) leading to inactivity or lead to 
proteins in which the catalytic properties are severely impaired. In addition, the 
exclusive formation of α-pinene by the active HAPS precludes further and more 
detailed mechanistic insights. From a chemical ecology point of view, the robust 
product specificity of HAPS uncovered by SDM may be beneficial for the Loblolly 
pine.  
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CHAPTER 5 
 
Synthesis and incubation of some chemically 
modified GDP analogues 
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5.1 Introduction 
 
The chemoenzymatic synthesis of (+)-verbenone (13) from GDP (4) described in 
chapter 3 demonstrates that terpene synthases (TS) are useful catalysts to construct 
synthetically challenging natural products in only a few chemical steps. More 
importantly, due to the often-observed substrate promiscuity of TPS, this synthetic 
approach appears ideal to prepare modified analogues of natural terpenes (Figure 5.1) 
with potentially novel biological properties. In this chapter, our efforts toward the 
synthesis of alkyl modified GDP’s as diphosphate surrogates of HAPS and their further 
enzymatic conversion are described.  
                                                  
 
 
Figure 5.1: Synthetic sequence to chemically modify (+)-α-pinene (12) and (+)-verbenone (13) 
analogues using alternative GDP’s.  	  
 
5.2 Preparation of pyrophosphate salts 
 
Few methods have been published to prepare prenyl pyrophosphates. The first protocol 
ever published involved treatment of an allylic alcohol with inorganic phosphate and 
trichloroacetonitrile.181 However, by this methodology, the final diphosphate required 
extensive purification, and hence the overall yield was often low. A better procedure to 
prepare primary allylic diphosphates was later introduced by Poulter et al.182 This route 
involves the conversion of an allylic alcohol into the corresponding halide (Cl or Br), 
and further nucleophilic displacement of the latter with pyrophosphate. In the present 
study, GDP (4) and all GDP analogues were prepared following this method as recently 
modified by Coates et al. (Scheme 5.1),183 which is essentially a modification of 
Poulter’s approach.   
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Scheme 5.1: Synthesis of geranyl diphosphate (4) from geraniol (89). 
 
Reagents and conditions: i) MsCl, Et3N, THF, LiBr, -45 C to 0 °C, 2 h; ii) (Bu4N)3HP2O7, MeCN, RT, 6 
h, 76% over the last two steps. 
 
To illustrate the two-step methodology of Coates, the synthesis of GDP (4) is given: 
geraniol (89) was first converted into the corresponding mesylate by treatment with 
methanesulfonyl chloride (MsCl) in the presence of a hindered base (eg. triethyl amine 
(Et3N)) at low temperature (0 °C). Then, addition of a solution of lithium bromide 
(LiBr) effects the nucleophilic substitution of the mesylate by Br- anion at room temp. 
Further exposure of the bromide (90) to the tris-tetrabutylammonium salt of 
pyrophosphoric acid in anhydrous acetonitrile (MeCN), subsequent ion exchange, and 
purification by reverse phase HPLC gives GDP (4) as the tris-ammonium salt in good 
yield.184 
 
 
O P O P O
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OO
OH89
Br90
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5.2.1 Synthesis of neryl diphosphate (NDP) 
 
For the synthesis of neryl diphosphate (NDP, 59) i.e. the Z-isomer of geranyl 
diphosphate (GDP, 4) the protocol of Barrero et al185 was followed to prepared the 
bromide. Thus, reaction of nerol with triphenylphosphine (Ph3P) and carbon 
tetrabromide (CBr4) resulted in the formation of neryl bromide (92).186  Allylic bromide 
92 was converted to the corresponding diphosphate 59 essentially as described for 
GDP182 following Poulter’s approach (Scheme 5.2). 
 
 
 
Scheme 5.2: Synthesis of neryl diphosphate (59) from nerol (91). 
 
Reagents and conditions: i) CBr4, Ph3P, C6H6, 0°C, 2.5 hr, used directly in the next step; ii) 
(Bu4N)3HP2O7, MeCN, RT, 6 hr, 65% over two steps. 
 
 
5.3 Synthesis of 8-methyl GDP 	  	  
The first step in this synthetic sequence was to oxidise the allylic acetate 93 at C8.  
Selenium dioxide (SeO2) was used for this step giving 90% yield (mixture of 94 and 
95). Secondly Swern oxidation was performed in order to produce only 94. Following 
this reaction with methyl triphenyl phosphonium bromide formed the alkene 96. 
Hydrogenation of 96 by Wilkinson’s catalyst produced the alcohol 98 after 
saponification of the resulting acetate 97. Activation of the alcohol as the allylic 
91
OH
92
Br
O P O P O
O O
OO59
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bromide 99, followed by reaction with tris tetrabutyl ammonium hydrogen 
pyrophosphate gave 8-methyl GDP pyrophosphate tetra-n-butylammonium salt 100. 
Cation-exchange chromatography followed by reverse phase HPLC purification finally 
gave the 8-methyl GDP 100 as a white solid, in over-all yield of 55.5% (98 to 100).	  	  	  
 
 
 
 
Scheme 5.3: Synthesis of 8-methyl GDP (100) from geranyl acetate (93). 
 
Reagents and conditions: tBuOOH, SeO2, DCM, CH2Cl2, C6H6(OH)COOH, 0 °C to RT, 30 hr, 90%; ii) 
(COCl)2, Et3N, DMSO, DCM, -78 °C to RT, O/N, 98%; iii) Ph3PCH3Br, n-BuLi, THF, -5 °C , 1hr, 52%; 
iv) (Ph3P)3RhCl, H2, C6H6CH3, RT, 24 hr; v) K2CO3, MeOH, RT, 85% vi) MsCl, Et3N, THF, LiBr, -45 °C 
to 0 °C, 2 hr; vii) (Bu4N)3HP2O7, MeCN, RT, 55%. 
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5.3.1 Allylic oxidation of geranyl acetate (84) with selenium dioxide 
and tert-butyl hydroperoxide  
 
The first step of the synthetic sequence outlined in Scheme 5.3 is the allylic oxidation of 
acetate 93 at C8.  Selenium dioxide is often the reagent of choice as it allows 
regioselective oxidations at the less hinder position in aliphatic chains such as 94.187 In 
the presence of tert-butyl hydroperoxide, the selenium oxidation of 84 is catalytic; the 
byproduct SeO is reoxidized back to SeO2, thus preventing/minimizing formation of the 
more harmful reduced forms of selenium.187 
 
 
 
Scheme 5.4: Mechanism for selenium dioxide oxidation.  
 
The mechanism of this reaction is believed to begin with deprotonation (Scheme 5.4) at 
C8, and concomitant electrophilic addition of SeO2 onto the C7,C8 double bond of 94. 
The resulting adduct undergoes allylic rearrangement and further solvolysis to generate 
alcohol 95. In the absence of an acid, or in stoichiometric amounts, the alcohol is 
oxidized further to the corresponding aldehyde 94.  To prevent this inconvenient side 
reaction, oxidation of 86 was more effectively accomplished by Swern oxidation.  
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5.3.2 Wittig olefination of 85 to form 87   
 
The Wittig reaction is an important method for the formation of alkenes. The double 
bond forms at the location of the original aldehyde or ketone. Here to convert aldehyde 
94 into 96, methyl triphenyl phosphonium bromide (Ph3PCH3Br) was used. The 
reactive ylide, prepared in situ by reaction with a strong base such us butyllithium (n-
BuLi), undergoes a 2+2 cycloaddition with aldehyde 94 to form an unstable 
intermediate that breaks down upon warming releasing the desired alkene product 96 
and triphenylphosphine oxide (Scheme 5.5) as the byproduct. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 5.5: Mechanism for Wittig olefination 
 
O RP
PhPh
Ph
CH3Br
P
PhPh
Ph
P
PhPh
Ph
CH
PPh
Ph
Ph O
R
RP Ph
O
Ph Ph
CH2 H
	   90	  
 
5.3.3 Hydrogenation of 96 using Wilkinson’s catalyst to give 97 
 
The complex RhCl(PPh3)3 (also known as Wilkinson’s catalyst) became the first highly 
active homogeneous hydrogenation catalyst that compared in rates with heterogeneous 
counterparts.190, 191  
 
Scheme 5.6: Mechanism for hydrogenation using Wilkinson’s catalyst 
 
 
This mechanism starts with an initial dissociation of a triphenyl phosphine group from 
the rhodium catalyst forming a 14e- complex.  This allows an oxidative addition of H2 
onto the metal followed by formation of the π-complex (between the alkene and the 
metal).  The alkene donates electron density into rhodium’s d orbital from the C=C 
atoms and the metal donates electrons back from a filled d orbital into the alkenes 
empty π-anti bonding orbital.  Both of these motions causes a weaker bond between the 
C=C atoms. The complex now is in an 18e- state. The final step is the reductive 
elimination of the desired alkane 97 to give a regenerated 14e- rhodium chloride 
complex.   
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5.3.4 Pyrophosphorylation of alcohol 98 to the 8-methyl GDP (100) 
 
Saponification of 97 using potassium carbonate/methanol gave alcohol 98 in 85% yield. 
This alcohol was converted into the corresponding diphosphate 100 (55%) via bromide 
99 following the methodology of Poulter.182 (See section 5.2). 
 
5.4 Synthesis of (E)-7-vinyl GDP (103) 
 
(E)-7-vinyl GDP 103 (Scheme 5.7) was prepared from alcohol 101 after saponification 
of acetate 96 (K2CO3/MeOH). This alcohol was then converted to bromide 102 
(MsCl/LiBr)
182 
and then treatment with tris (tetra-n-butylammonium) 
hydrogenpyrophosphate in anhydrous acetonitrile to give 103 in 35% overall yield. 
 
  
 
 
Scheme 5.7: Synthesis of (E)-7-vinyl GDP (103) from geranyl acetate (93). 
 
Reagents and conditions: i) MsCl, Et3N, THF, LiBr, -45 °C to 0 °C, 2 hr; ii) (Bu4N)3HP2O7, MeCN, RT, 
45% over the last two steps.  
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5.5 Synthesis of 10-methyl GDP (114) 
 
 
 
 
Scheme 5.8: Synthesis of 10-methyl GDP (114) from geraniol  (89) 
 
Reagents and conditions: i) 3,4-DHP, p-TsOH,(C2H5)2O, RT, 18 hr, 88%; ii) NBS, THF/H2O, -5 °C, 4 hr, 
71%; iii) DBU,THF, 0 °C to RT , 4hr, 87%; iv) H5IO6, 0 °C, 45 min, 57%  v) 
(CF3CH2O)2P(O)CH(CH3)CO2Et, THF, KHMDS,18-crown-6, -78 °C, 1 hr; vi) DIBAL-H, THF, -20 °C, 3 
hr, 87%, vii) MnO2, C6H14, 0 °C, 3 hr, 86%; viii) Ph3PCH3Br, n-BuLi, THF, -5 °C , 1hr, 55%;  ix) 
(Ph3P)3RhCl, H2, C6H6CH3, RT, 24 hr, 80% and then PPTS, EtOH, 55 °C , 2 hr, 85%;  x) MsCl, Et3N, 
THF, LiBr, -45 °C to 0 °C, 2 hr; xi) (Bu4N)3HP2O7, MeCN, RT, 40% over the last two steps 
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The synthesis of 114 started with protection of geraniol as the tetrahydropyranyl (THP-) 
ether derivate 104.92,93 Subsequent hydrobromination of the terminal double bond with 
N-bromosuccinimide in water afforded a mixture of bromohydrins 105.  
Mechanistically, this reaction involves the electrophilic addition of bromine across the 
double bond to form a reactive bromonium ion that is further displaced by the 
nucleophile (water) to yield 105 and succinimide as a by-product.194 Epoxide 106 is 
then formed when 105 is exposed to base (eg. 1,8-diazobicycloundec-7-ene (DBU)). 
The alkoxide intermediate displaces intramolecularly the adjacent bromide affording the 
epoxide 106.195 
 
Reaction of epoxide 106 with sodium periodate causes an oxidative cleavage between 
C6 and C7 to forms the shorter aldehyde 107. The reaction proceeds through the 
formation of a strained 5 membered ring intermediate that breaks down oxidatively into 
acetone and the aldehyde 107 required for the next step (Scheme 5.9). 
 
 
 
Scheme 5.9:  Mechanism of oxidative cleavage with the use of sodium periodate 
 
The Z-configured ethyl ester 108 was synthesized following a modification of the 
Horner-Emmons olefinations.196, 197 Reduction of the ester 108 with DIBAL-H gave 
alcohol 109.17 The next oxidation of 109 to the aldehyde 110 was carried out using 
activated manganese (IV) oxide. Wittig olefination of the latter using methyl triphenyl 
phosphonium bromide (Ph3PCH3Br), hydrogenation of diene 111 with Wilkinson’s 
catalyst, and THP deprotection (pyridinium p-toluenesulphonate) gives alcohol 112. 
This was then converted to the desired 10-methyl GDP analogue 114 (40% from 112) 
via bromide 113 as described earlier.
182 
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5.6 Synthesis of (Z)-7-vinyl GDP (117) 
 
The synthesis of (Z)-7-vinyl GDP (117) was accomplished by Poulter’s method using 
allylic alcohol 115 (Scheme 5.10), which was synthesized from the corresponding THP 
ether 111 (See section 5.5), during the synthesis of compound 114. 
 
 
 
 
Scheme 5.10: Synthesis of (Z)-7-vinyl GDP (117) from compound 89 
 
Reagents and conditions: i) PPTS, EtOH, 55 °C, 2 hr, 92%; ii) MsCl, Et3N, THF, LiBr, -45 °C to 0 °C, 2 
hr; iii) (Bu4N)3HP2O7, MeCN, RT, 43% over the last two steps. 
 
5.7 Incubation of GDP analogues with HAPS 
 
2-Fluoro GDP (118), 2,3-dihydroGDP (119) and 9-Methyl GDP (120) were synthesised 
by Dr. Juan Faraldos. To check the ability of HAPS to produce α-pinene derivatives 
with GDP analogues such as 8-methyl GDP (100), (E)-7-vinyl GDP (103), 10-methyl 
GDP (114), (Z)-7-vinyl GDP (117), 2-Fluoro GDP (118), 2,3-dihydroGDP (119) and 9-
methyl GDP (120) was assessed by GC-MS using analytical scale incubations. In brief, 
HAPS (20 µM) was incubated with GDP analogues (2.0 mM, 25 µL) in buffer (0.5 mL 
total volume, 100 mM Bis-Tris propane, pH 7.5, 50 mM KCl and 20 mM MgCl2). The 
aqueous enzymatic medium was overlaid with 0.5 mL pentane to capture volatiles. 
After gentle shaking overnight at room temperature, the organic layer was removed and 
the aqueous layer was extracted with additional pentane (0.5 mL). The pooled pentane 
OTHP
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extracts were filtered through silica gel column (≈3 g silica) and the eluent was 
analyzed by GC-MS. 
 
 
 
 
Figure 5.2: Incubation results of GDP analogues with HAPS 
 
 
Compounds 118 and 119 proved not to be a substrate for HAPS giving no peak on the 
GC spectra corresponding to the formation of the (+)-α-pinene analogues. All the other 
GDP analogues, 100, 103, 114, 117 and 120 are substrates for HAPS giving the 
corresponding (+)-α-pinene analogues. These will be described in more detail in the 
following paragraphs. 
 
 
5.7.1 Incubation results for 8-methyl GDP  
 
As described in Scheme 1.6 for GDP (4), we can imagine that 8-methyl diphosphate 
(100) may undergo a similar pathway as GDP. Indeed, the extra methyl at the C8 
position is not involved at any time in the catalytic pathway of HAPS. The only 
problem could be steric hindrance in the catalytic active site due to a bigger size of the 
substrate. 
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As illustrated in scheme 5.11, 8-methyl GDP could lead to the corresponding 8-methyl 
linalyl diphosphate (121) as for GDP.  Then ionization of 121 followed by ring closures 
and final deprotonation would lead to the formation of the analogue of (+)-α-pinene 
124. 
 
 
 
 
 
Scheme 5.11: Proposed mechanism for the conversion of 8-methyl GDP (91) to (S)-(+)-α-methylpinene 
(124)  
 
 
 
GC-MS analysis of the pentane extract layer of incubation of 8Me GDP with HAPS 
showed the formation of a single peak at t = 11.08 min displaying m/z = 150 
corresponding to the m/z of 124 and a mass spectrum similar to the one of (+)-α-pinene. 
This would suggest the obtaining of the (S)-(+)-α-methylpinene 124.  
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Figure 5.3: A) Gas chromatogram of the novel analogue, (S)-(+)-α-methylpinene 124; B) MS of the GC 
peak at retention time 10.52 seconds; C) MS of the peak at retention time 11.06 seconds 
 
5.7.2 Incubation results for (E)-7-vinyl GDP (103) 
 
As described for 8-methyl GDP in the previous paragraph, (E)-7-vinyl GDP may 
undergo a similar pathway as GDP and so incubation of (E)-7-vinyl GDP could lead to 
the formation of the corresponding (+)-α-pinene analogue: (S)-(+)-α-7-vinylpinene 125. 
 
 
 
Scheme 5.12: Proposed conversion of (E)-7-vinyl GDP (103) to (S)-(+)-α-7-vinyllpinene (125) by 
HAPS.  
 
GC-MS analysis of the pentane extract layer of incubation of (E)-7-vinyl GDP 103 with 
HAPS showed the formation of a single peak at t = 10.38 min displaying a m/z = 148 
corresponding to the m/z of 125 and a mass spectrum similar to the one of (+)-
α−pinene. This would suggest that (S)-(+)-α-7-vinylpinene 125 was obtained.  
OPP
103 125
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Figure 5.4: A) Gas chromatogram of the novel analogue, (S)-(+)-α-7-vinylpinene; B) MS of the peak at 
retention time 10.38 minutes 
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5.7.3 Incubation results for 10-methyl GDP (114) 
 
As previously described for 8-methyl GDP (100), 10-methyl GDP (114) may undergo a 
similar pathway as GDP and so incubation of 10-methyl GDP could lead to the 
formation of the corresponding (+)-α−pinene analogue: (R)-(+)-α-10-methylpinene 
126. 
 
Scheme 5.13: Proposed conversion of 10-methyl GDP (114) to (S)-(+)-α-10-methylpinene (126) by 
HAPS.  
 
GC-MS analysis of the pentane extract layer of incubation of 10-methyl GDP 114 with 
HAPS showed the formation of a single peak at t = 10.95 min displaying a m/z = 150 
corresponding to the m/z of 126 and a mass spectrum similar to the one of (+)-pinene. 
This would suggest that (R)-(+)-α-10-methylpinene 126 was obtained. 
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Figure 5.5: A) Gas chromatogram of the novel analogue, (R)-(+)-α-methylpinene; B) MS of the peak at 
retention time 10.95 minutes. 
 
 
5.7.4 Incubation results for (Z)-7-vinyl GDP (117) 
 
As previously described for 8-methyl GDP, (Z)-7-vinyl GDP may undergo a similar 
pathway as GDP and so incubation of (Z)-7-vinyl GDP could lead to the formation of 
the corresponding (+)-α−pinene analogue: (R)-(+)-α-7-vinylpinene 127. 
 
 
Scheme 5.14: Proposed conversion of (Z)-7-vinyl GDP (117) to (R)-(+)-α-7-vinyllpinene (127) by 
HAPS.  
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GC-MS analysis of the pentane extract layer of incubation of (Z)-7-vinyl GDP 117 with 
HAPS showed the formation of a major peak at t = 10.33 min displaying a m/z = 148 
corresponding to the m/z of 127 and a mass spectrum similar to the one of (+)-
α−pinene. This would suggest that (R)-(+)-α-7-vinylpinene 127 was obtained. 
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Figure 5.6: A) Gas chromatogram of the novel analogue, (R)-(+)-α-7-vinylpinene; B) MS of the peak at 
retention time 10.33 minutes. 
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5.8 Conclusions 
 
Modification of the second isoprene unit, at C8 or C10 by a extra methyl or methylene 
group has no effect on the catalytic process. Indeed, isomerization on trans (geranyl) to 
cis (neryl) (LDP) needed for cyclization can occur (Scheme 5.10) followed by the 
carbocation cascade and proton elimination leading to the formation of the 
corresponding (+)-α-pinene analogues. 
 
 
 
 
 
 
 
Figure 5.5: (+)-α-pinene analogues obtained by converstion of GDP analogues with HAPS 
 
Modification in the first isoprene unit of GDP by addition of an extra methyl, fluorine 
or removal of the C2-C3 double bond stops the catalytic process at the first step. Indeed, 
no formation of any intermediate or final product from the catalytic cascade is observed 
by GC-MS analysis. So it seems that 2-fluoroGDP (118), 2,3-dihydroGDP (119) and 9-
methyl GDP (120) may inhibit conversion of GDP to LDP. For 2,3-dihydroGDP (119), 
the presence of the 2,3-double bond of the substrate is essential for cyclisation to occur 
in the biosynthesic pathway (Scheme 1.6). For the 2-fluoroGDP (118), it is based on 
electronegativity of the fluorine group. The electron withdrawing fluorine substituent 
would be expected to retard/inhibit ionisation at the geranyl cation (Scheme 1.6).107 
 
For 9-methyl GDP (120), it may be difficult to form LDP based on steric hindrance 
(bulkiness of ethyl group versus methyl group). It may be difficult to overcome the 
topological impediment to direct cyclisation, imposed by the trans geometry of the C2–
C3 double bond or due to the steric hindrance, making the compound unable to go into 
the active site of the enzyme to react. 
 
124 125 126 127
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However, it was not possible to do preparative incubation with GDP analogues in order 
to obtain a 1H NMR of the final compounds. A long investigation on incubation 
conditions would be needed. 
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CHAPTER 6 
 
General conclusions and future work 
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The monoterpene synthase α-pinene synthase was used as a pilot synthetic platform to 
produce high-value mono-oxygenated terpenoids. Heterologous expression, purification 
and characterization of recombinant (+)-α-pinene synthase are performed. Several 
expression conditions and many purification methods were tried in order to get 
optimum results. The plant gene was first codon optimised for expression in E. coli. 
Codon optimization can alter both naturally occurring and recombinant gene sequences 
to achieve the highest possible levels of productivity in any given expression system by 
increasing the translational efficiency. However, after gene design and expression, (+)-
α-pinene synthase was obtained as inactive inclusion bodies and several protein 
purification techniques were needed in order to get soluble, catalytically active (+)-α-
pinene synthase. Several different purification protocols were attempted with this 
particular synthase, including ion exchange chromatography, ammonium sulphate 
precipitation, hydrophobic interaction chromatography and size exclusion 
chromatography before introducing affinity chromatography.  
 
Although His-tagged terpene synthases are catalytically active when expressed, such 
fusions are, in some cases, inappropriate for detailed crystallographic studies.88,137-139  A 
concern however, is that the presence of the his-tag may affect the enzyme activity and 
so, in addition, it was decided to insert a TEV (Tobacco Etch Virus) cleavage site 
between the (+)-α-pinene synthase gene and the N-terminal his-tag. After purification 
by Ni affinity chromatography, the ability of (+)-α-pinene synthase to produce (+)-α-
pinene was assessed. The kinetic evaluation (KM and kcat) of (+)-a-pinene synthase was 
carried out using radiolabelled [1-3H]-GDP under optimised reaction conditions (vide 
supra). The KM value was found to be 40 ± 8 µM, and the kcat value 0.001 ± 0.0004 s-1. 
The KM value is in good agreement with those previously reported.15 The N-terminal 
hexa-histidine tag did not appear to affect the activity of the enzyme and all further 
experiments were performed with His-tagged (+)-α-pinene synthase (HAPS). 
 
Using monoterpene synthase (α-pinene synthase, HAPS) as a platform to produce 
important pheromones (verbenone or verbenol) directly from geranyl diphosphate can 
be used as a novel chemoenzymatic approach. A chemoenzymatic synthesis of (+)-
verbenone in 50% yield and >98% optical purity was achieved in two steps starting 
from geranyl diphosphate.  This method favorably compares to previous syntheses as it 
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avoids the isolation of intermediates (α-pinene/verbenol) and is, for the most part, 
devoid of undesirable by-products. Although verbenone is a cheap commercially 
available natural product, this pilot project was intended mostly as a proof of concept 
using a relatively simple target, and hence accumulate valuable evidence to assess in-
depth the suitability of the approach to target more complex terpenoids such as 
artemisinin and artemisinin derivates in future. 
 
The chemoenzymatic synthesis of (+)-verbenone from geranyl diphosphate 
demonstrates that terpene synthases are useful catalysts to construct synthetically 
challenging natural products in only a few chemical steps, with potentially novel 
biological properties. These engineered (+)-α-pinene analogues may display enhanced 
biological activities due to the potential improvement of their physical properties. More 
geranyl diphosphate analogues can be synthesized in future (using phenyl-, fluoro-
functional groups). 
 
Finally, a site directed mutagenesis strategy was employed to HAPS to examine the 
potential catalytic role of four aromatic amino acids, in stabilizing the carbocationic 
intermediates generated in the active site of HAPS during the natural conversion of 
geranyl diphosphate to the monoterpene (+)-α-pinene. The replacement by residues of 
different electrostatic and hydrogen bonding properties drastically changed either the 
HAPS structure (folding) leading to inactivity or lead to proteins in which the catalytic 
properties were impaired. Tandem arginine pairs are good target for future mutagenesis 
studies for HAPS. 
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CHAPTER 7 
 
Materials and methods 
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7.1 Materials 
 
Oligonucleotide primers for site directed mutagenesis were purchased from Eurofins 
MWG|Operon. A synthetic gene for α-pinene synthase from loblolly pine (Pinus taeda) 
was cloned into NcoI, BamHI digested pET 21d (EpochBioLabs) using methods in   
previous work within the Allemann group. Chemicals were purchased from Chemodex, 
Fisher, Fluka, GE Healthcare, Merck, New England Biolabs, NovaBiochem, QIAGEN 
or Sigma-Aldrich. DNA primers (oligonucleotides) were purchased from Operon or 
Sigma-Aldrich. 
 
1H-NMR spectra were measured on a Bruker Avance DPX400 NMR spectrometer and 
are reported as chemical shifts in parts per million downfield from tetramethylsilane, 
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet), coupling 
constant (to the nearest 0.5 Hz) and assignment, respectively. IR spectra were recorded 
on a Perkin-Elmer 1600 series FTIR spectrometer and samples were prepared as thin 
films of neat liquid on sodium chloride discs. GC-MS analyses were performed on a 
Hewlett Packard 6890 GC fitted with a J&W scientific DB-5MS column (30 m x 0.25 
mm internal diameter) and a Micromass GCT Premiere mass spectrometer detecting in 
the range m/z 50-800 in EI+ mode with scanning once a second with a scan time of 0.9 
s. Injections (10 µL) were performed in split mode (split ratio 5:1) at 50 °C. 
Chromatograms were begun with an oven temperature of 49 °C, which was held for 1 
min and then increased at 4 °C min-1 for 25.25 min up to 150 °C. Chiral GC analyses 
were performed on a Perkin Elmer 8700 Gas Chromatograph using a Supelco 23404 
beta-Dex L20 column (30 m x 0.25 mm internal diameter) with an FID detector. 
Chromatograms were performed isothermally at 80 °C for 〈-pinene and 110 °C for 
verbenone with the injector at 200 °C. 
 
Centrifuges used were as follows: 
Eppendorf 5415 benchtop microcentifuge 
Thermo IEC 243 Centra CL3R centrifuge, Thermo Fisher Scientific Inc, USA 
Innova 43 shaker (New Brunswick Scientific, UK) 
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7.1.1 Primers for inserting TEV cleavage site to his-tagged protein 
 
Oligonucleotides for site-directed mutagenesis were purchased from Eurofins 
MWG|Operon. The primers were as follows (5’ to 3’) and both primers were 
phosphorylated at the 5’ end. 
 
 
Forward- CACCACCACCACCACCAC  
Reverse- GCCCTGAAAATACAGGTTTTCCAGTGGGACGGTTTCGAC  
 
7.1.2 Primers for site-directed mutagenesis 
 
Oligonucleotides for site-directed mutagenesis were purchased from Eurofins 
MWG|Operon. 
The primers were as follows (5’ to 3’), with the changed triplet underlined and the 
changed bases in italics: 
 
 
HAPS-Y601A forward:  
CGTGTTTCATTACGGCGCGAAATACCGTGACGGC 
HAPS-Y601A reverse: GCCGTCACGGTATTTCGCGCCGTAATGAAACACG  
 
HAPS-F607A forward: CAAATACCGTGACGGCGCGAGTGTGGCCAGTATTG 
HAPS-F607A reverse:  CAATACTGGCCACACTCGCGCCGTCACGGTATTTG 
 
HAPS-F597A forward: CTTTGACATTTGCCGCGTGGCGCATTACGGCTACAAATAC 
HAPS-F597A reverse: GTATTTGTAGCCGTAATGCGCCACGCGGCAAATGTCAAAG 
                                        
 
HAPS-F480A forward:  
CGGGAAAGTCAGCGCGGGCAGCCGCATCAC 
HAPS-F480A reverse:   
GTGATGCGGCTGCCCGCGCTGACTTTCCCG 
 
HAPS-Y601F forward: CGCGTGTTTCATTACGGCTTTAAATACCGTGACGGCTTTAG 
HAPS-Y601F reverse: CTAAAGCCGTCACGGTATTTAAAGCCGTAATGAAACACGCG 
 
 
HAPS-F607Y forward: CAAATACCGTGACGGCTATAGTGTGGCCAGTATTG 
HAPS-F607Y reverse:  CAATACTGGCCACACTATAGCCGTCACGGTATTTG 
 
HAPS-F607L forward: CAAATACCGTGACGGCCTGAGTGTGGCCAGTATTG 
HAPS-F607L reverse:  CAATACTGGCCACACTCAGGCCGTCACGGTATTTG 
 
HAPS-Y601L forward: CCGCGTGTTTCATTACGGCCTGAAATACCGTGACGGCTTTAG 
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HAPS-Y601L reverse:  CTAAAGCCGTCACGGTATTTCAGGCCGTAATGAAACACGCGG 
 
HAPS-F597Y forward: CTTTGACATTTGCCGCGTGTATCATTACGGCTACAAATAC 
HAPS-F597Y reverse:  GTATTTGTAGCCGTAATGATACACGCGGCAAATGTCAAAG 
 
 
HAPS-F597L forward: CTTTGACATTTGCCGCGTGCTGCATTACGGCTACAAATAC 
HAPS-F597L reverse:  GTATTTGTAGCCGTAATGCAGCACGCGGCAAATGTCAAAG 
 
HAPS-F480Y forward: GGAAAGTCAGCTATGGCAGCCGCATC 
HAPS-F480Y reverse:  GATGCGGCTGCCATAGCTGACTTTCC 
 
HAPS-F480L forward: GAGAACGGGAAAGTCAGCCTGGGCAGCCGCATCACTACTC 
HAPS-F480L reverse: GAGTAGTGATGCGGCTGCCCAGGCTGACTTTCCCGTTCTC 
 
The oligonucleotides were designed taking the following considerations into 
account:                 
 
1. Both primers should have the desired mutation and must anneal to the same sequence 
on opposite strands of the parent plasmid. 
2. The primers should be 25-45 bases in length and melting temperature, Tm should be 75 
to 85 °C. 
3. The primers should contain 40 to 60 % of GC residues and also terminate in one or 
more C or G bases. 
4. The protocol used was that supplied with the Quick-change Site-Directed Mutagenesis 
Kit from Stratagene and the expression system was Escherichia coli. 
All the above parameters were calculated using the following website: www.bioinformatics.org/primerx/index.html. 
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7.2 Growth media 
 
7.2.1 LB and YT media 
 
LB medium was prepared by dissolving 10 g/L of tryptone, 10 g/L NaCl and 5 g/L 
bacto-yeast extract, in water and then adjusting the solution to pH 7.5. 
 
YT medium was prepared by dissolving 16 g/L of tryptone, 5g/L NaCl and 10 g/L 
bacto-yeast extract in water and adjusting the solution to pH 7.5. 
 
7.2.2 LB agar plates 
 
LB agar plates were prepared by adding 7.5 g of agar to 500 mL of LB media. The 
solution was autoclaved, and then 90 mg of ampicillin-sodium were added to the warm 
solution once it had cooled to ~40 °C. The mixture was poured into petri dishes and left 
to solidify, and stored at 4  °C. 	  
7.3 E. coli strains 
 
7.3.1 Cloning strains 
 
For sequencing, the XL1-Blue strain was used. This is an excellent host strain for 
routine cloning because these cells have high transformation efficiency. 
 
7.3.2 Expression strains 
 
For large-scale expressions of HAPS, the E. coli strain BL21 Codon plus (DE3)-RIL 
was used. It carries a T7 RNA polymerase under the control of a lac UV5 promoter. 
Codon plus RIL cells are codon enriched R, L and I that are mostly used by plants and 
are often used to express plant genes in bacterial hosts.  
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7.4 Preparation of Buffers 
7.4.1 Lysis buffer 
 
For 1 L of lysis buffer, 6 g of Tris-base (50 mM), 1.85 g EDTA (5 mM), 350 µL β-
mercaptoethanol (5 mM) and 100 mL Glycerol (10% v/v) were fully dissolved in 
deionized water. The pH was adjusted to 8.0. 
 
7.4.2 Dialysis Buffer 
 
For 3 L of dialysis buffer, 3.6 g of Tris-base (10 mM) and 1048 µL β-mercaptoethanol 
(5 mM) were dissolved in deionized water and the pH was adjusted to 7.5 
 
7.5.1 Insertion of a TEV cleavage site into the hexahistidine-tag protein 
using PCR 
 
Insertion of the desired primer was performed using Phusion Site Directed Mutagenesis 
Kit (New England Bio Labs).  
 
The reaction mixture contained                      µL 
 
H2O (sterilized)                      31.5  
5× Phusion HF buffer                        10.0 
10 mM dNTP’s                                          1.0 
Primer A     2.5 
Primer B  2.5 
Template DNA (1ng)  1 
Phusion hot start polymerase   0.5                       
  
The PCR reaction was carried out using temperature cycles as follows: 
 
1) 98°C 30 sec   (Initial denaturation) 
2) 98°C 10 sec   (Denaturation of template) 
3) 67°C 30 sec   (Annealing) 
4) 72°C 3.6 min (Extension at 30 sec per kilobase) 
5) 72°C 10 min  (Final extension) 
  4°C hold 
 
25 cycles were performed for steps (2-4) 
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7.5.2 Ligation 
 
The PCR product was circularised with quick T4 DNA ligase in a 5 min reaction as 
follows, 
Take 5µl of PCR product. 5µl of 2 × quick ligation buffer was added with mixing. 0.5µl 
of quick T4 DNA ligase was added with mixing. The final mixture was mixed well for 
2-3 sec and incubated at room temperature for 5 min and then chilled on ice.  The PCR 
product was then transformed in to E. coli XL1 Blue cells as described below. 
 	  
7.5.3 Site-directed mutagenesis using PCR 
 
The Promega Pfu kit was used for all site directed mutagenesis work. 
 
The reaction mixture contained                                    µL 
 
Pfu DNA polymerase buffer (10x) 5.0 
Primer A                  2.0 
Primer B               2.0 
                  Template DNA               1.0  
10 mM dNTP’s                                                       1.0 
Pfu DNA polymerase                1.0                       
                   H2O (sterilized)                                   39.0 
 
The PCR reaction was carried out using temperature cycles as follows: 
 
1) 95°C     3 min   (Activation of heat sensitive Pfu polymerase) 
2) 95°C     1 min   (Denaturation of template) 
3) 67°C     2 min   (Annealing) 
4) 72°C     15 min (Extension at 2 min per kilobase) 
5) 72°C     10 min  (Final extension) 
  4°C     hold 
 
15 cycles were performed for steps (2-4) 
             
The PCR product was then digested with Dpn 1 (1 µL) endonuclease (target sequence: 
5’- GATC – 3’ with methylated alanine) to remove all parental DNA. This mixture was 
incubated at 37 °C for 1hour. 
 
XL1-Blue cells were then transformed with 5 µL of Dpn 1 treated DNA solution. The 
transformation mixture was incubated on ice for 30 min. After a heat shock at 42° C for 
45 s, 1 mL of LB media was added. The resulting mixture was incubated at 37° C for 1 
h. The resulting cells were harvested by microcentrifugation at 13000 rpm for 1 min. 
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The pellet obtained was resuspended in LB media (20 µL) and spread onto LB agar 
plates containing ampicillin (0.18 mg/mL Agar). The LB agar plates were incubated at 
37° C overnight. 
 
7.6 Agarose gel electrophoresis  
 
7.6.1 50 x TAE buffer 
 
Tris base (242 g), acetic acid (57.1 mL) and 100 mL of EDTA (0.5 M) were dissolved 
in 1 L of water and the solution adjusted to pH 8. 
 
Agarose (0.5 g) was dissolved in 50 mL of TAE (50X) buffer. The mixture was heated 
in a microwave oven until the agarose was fully dissolved (0.5 -1 min) and then the 
mixture was poured in to a BioRad Mini-Gel kit fitted with a comb and allowed to set.  
5 µL of DNA sample was mixed with 10 µL of DNA dye (30% glycerol, 0.5% 
bromophenol blue and water) and loaded to the wells. The gel was run at 60 mA for 60 
min. 
 
7.6.2 Ethidium bromide 
 
25 µM ethidium bromide stock solutions were prepared by dissolving ethidium bromide 
(8.1g) in 100 mL of deionised water. This solution was stored in the dark at 4 °C. For 
gel staining, a working concentration of 6 µM was prepared by diluting 48 µL of stock 
solution to 200 mL with deionised water. 
 
7.7 DNA purification using QIA MiniPrep Kit Protocol 
 
The 10 mL overnight cultures in LB medium containing 0.27 µM ampicillin were 
centrifuged at 4000 rpm for 10 min. 
The pellets were resuspended in 250 µL of buffer P1 and transferred to a micro 
centrifuge tube following which 250 µL of buffer P2 was added and mixed thoroughly 
by inverting the tubes 4-6 times. After that 350 µL of Buffer N3 was added and mixed 
in immediately by inverting the tube 4-6 times. The solution became cloudy upon the 
addition of N3. This solution was centrifuged for 10 min at 13,000 rpm in an Eppendorf 
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5415 benchtop microcentifuge. Following centrifugation, supernatants were then 
transferred from the Eppendorf to the QIAprep spin column by decanting. This solution 
was again centrifuged for 1 min and the flow through was discarded. The QIAprep spin 
column was washed with 0.75 mL of Buffer PE and centrifuged for 1 min at 13,000 
rpm. The flow through was discarded, and the QIAprep spin column was centrifuged 
for an additional 1 min to remove residual wash buffer. Finally the QIAprep column 
was placed in a clean 1.5 mL micro centrifuge tube. At this stage to elute the DNA, the 
QIAprep spin column was placed on an Eppendorf and 50 µL of Buffer EB passed 
through the center of QIAprep spin column, This was allowed to stand for 1 min, and 
centrifuged for 1 min. Finally DNA was collected in the Eppendorf and the spin column 
was discarded. 
 
7.8 DNA mini prep buffers 
 
Buffer P1 (suspension buffer) 
Tris-HCl (157.6 mg, 50 mM), EDTA (58.448 mg, 10 mM) and RNase A (50 µg/ml final 
concentration) were dissolved in 15 mL of deionised water. The pH was adjusted to 8.0 
and the total volume adjusted to 20 mL with deionised water. The solution was stored at 
4 °C. 
 
Buffer P2 (lysis buffer) 
NaOH (4 g, 0.4 M) and SDS (5 g, 2% w/v) were dissolved in separate portions of 
deionised water (200 mL). The solutions were combined and the total volume was 
adjusted to 500 mL. The final solution was stored at room temperature. 
 
Buffer N3 (neutralization and binding buffer) 
 
Guanidine hydrochloride (7.6 g, 4M), and potassium acetate (981.4 mg, 0.5 M) were 
dissolved in 15 mL of deionised water. The pH was adjusted to 4.2 and the total volume 
was adjusted to 20 mL with deionised water and the solution was stored at room 
temperature. 
 
 
 
Buffer PB (wash buffer) 
Guanidine hydrochloride (9.5 g, 5M), Tris-HCl (63.0 mg, 20 mM) and ethanol (7.6 mL, 
38% v/v) were added to 8 mL of deionised water. The pH was adjusted to 6.6 and the 
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total volume was adjusted to 20 mL with deionised water. The solution was stored at 
room temperature. 
 
Buffer PE (wash buffer) 
NaCl (23.4 mg, 20 mM), Tris-HCl (6.3 mg, 2 mM) and ethanol (16 mL, 80% v/v) were 
added to 2 mL of deionised water. The pH was adjusted to 7.5 and the total volume was 
adjusted to 20 mL with deionised water. The solution was stored at room temperature. 
 
Buffer EB (Elution buffer) 
Tris-HCl (32 mg, 10 mM) was dissolved in 15 mL of deionised water. The pH was 
adjusted to 8.5 and the total volume was adjusted to 20 mL with deionised water. The 
solution was stored at room temperature. 
 
7.9 SDS-Polyacrylamide gel electrophoresis 
 
7.9.1 SDS stacking buffer 
 
Tris-base (6 g, 0.5 M) was dissolved in 80 mL of deionised water and the pH adjusted 
to 6.8 with 6 M HCl. The total volume was adjusted to 100 mL with deionoised water 
and the resulting solution was stored at room temperature. 
 
7.9.2 SDS resolving buffer 
 
Tris-base (27.23 g, 1.5 M) was dissolved in 100 mL of deionised water and the pH 
adjusted to 8.8 with 6 M HCl. The total volume was adjusted to 150 mL with de-ionised 
water and stored at room temperature. 
 
7.9.3 10% (w/v) sodium dodecyl sulfate (SDS) 
 
Sodium dodecyl sulfate (10 g) was dissolved in 90 mL of deionised water. After the 
solid was fully dissolved, the volume was adjusted to 100 mL and the solution was 
stored at room temperature. 
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7.9.4 10% (w/v) Ammonium persulfate 
 
Ammonium persulfate (100 mg) was dissolved in 1 mL of deionised water. The solution 
was freshly made each time. 
 
7.9.5 SDS electrode running buffer (10x) 
 
Tris-base (30.3 g, 250 mM), glycine (150 g, 2 M) and sodium dodecyl sulfate (10.0 g) 
were fully dissolved in 900 mL of deionised water. The total volume was adjusted to 1 
L and stored at 4 °C. The concentrated solution was diluted 10 fold before use with 
deionised water. 
 
7.9.6 SDS staining solution 
 
Coomassie brilliant blue (R-250) (0.25 g), was dissolved in a mixture of methanol,water 
and glacial acetic acid (45 mL, 45 mL and 10 mL respectively) this solution was stored 
at room temperature. 
 
7.9.7 SDS destaining solution 
 
Ethanol (40%) and glacial acetic acid (10%) were mixed then the total volume was 
adjusted to 1 L. 
 
7.9.8 SDS-PAGE protocol 
 
Gel solutions were prepared by mixing the reagents described in the table below. The 
gel solutions were poured in-between two glass plates. 100 µL of APS and 15 µL of 
TEMED were added to both the resolving and stacking solutions just prior to pouring 
the gel. Solutions were mixed gently to initiate polymerization. Firstly, resolving 
solution was poured into the gap between the glass plates just to reach the bottom line 
of the wells when the combs were inserted. Once the resolving gel was set, isopropanol 
was removed using blotting paper and the stacking gel solution was poured until over-
flowing and a comb was inserted to create wells for sample loading. For analysis of 
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HAPS 5% stacking and 12% resolving gels were used. Finally gels were stained with 
staining solution and then destained.  
 
Gel (%) dH2O (mL) 30% Degassed 
Acrylamide-Bis (mL) 
Gel Buffer 
(mL) 
4 6.1 1.3 2.5 
5 5.7 1.7 2.5 
6 5.4 2.0 2.5 
7 5.1 2.3 2.5 
8 4.7 2.7 2.5 
9 4.4 3.0 2.5 
10 4.1 3.3 2.5 
11 3.7 3.7 2.5 
12 3.4 4.0 2.5 
13 3.1 4.3 2.5 
14 2.7 4.7 2.5 
15 2.4 5.0 2.5 
16 2.1 5.3 2.5 
17 1.7 5.7 2.5 
 
 
 
7.10 Preparation of Competent Cells 
 
Non-competent cells (BL21-CodonPlus (DE3)-RIL cells)	   from glycerol stocks (2 µL) 
were used to inoculated LB media (100 mL) and then incubated in a shaker overnight at 
37 °C. 1 mL of the overnight culture was used to inoculated LB media (100 ml) and 
incubated at 37 °C until an optical density of 0.6 (600 nm) was reached. The cells were 
centrifuged for 10 min at 4000 rpm (Thermo IEC 243 Centra CL3R centrifuge, Thermo 
Fisher Scientific Inc, USA) and the supernatant solution was discarded. The pellet was 
re-suspended in 5 mL of sterilized CaCl2 solution (100 mM) and incubated on ice for 20 
min before harvesting the cells through centrifugation as above. The resulting pellet was 
re-suspended in 6 mL of sterilized CaCl2 and 15 % (v) glycerol as their OD units (1 mL 
of CaCl2 and 15 % (v) glycerol per 0.1 unit of OD). This mixture was incubated on ice 
for 20 min and then aliquoted to sterile Eppendorf tubes (100 µL) and flash frozen in 
liquid nitrogen for storage at -80 °C. 
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7.11 Preparation of Super-Competent Cells 
  
Tfb 1 
 
Potassium acetate (0.59 g, 30 mM), rubidium chloride (2.42 g , 100 mM), calcium 
chloride (0.29 g , 910 mM), manganese chloride (2.00 g , 50 mM,) were dissolved 15% 
glycerol 15 %  in water (v/v, 80 mL) mixed together and pH adjusted to 5.8 with dilute 
acetic acid. The solution was then diluted to a final volume of 200 mL with deionised 
water. 
 
Tfb 11 
 
MOPS (0.21 g, 10 mM), calcium chloride (1.1 g, 75 mM), rubidium chloride (0.121 g, 
10 mM) were dissolved 15 % glycerol 15 % in water (v/v) mixed together and pH 
adjusted to 6.5 with dilute NaOH. The solution was then diluted to a final volume of 
100 mL. 
 
Non-competent cells from glycerol stocks (5 µL) were used to inoculate LB medium 
(100 mL) and the culture was incubated in a shaker overnight at 37 °C. 1 mL of 
overnight culture was used to inoculate LB medium (100 ml) and incubated at 37 °C 
until an optical density of 0.6 (600 nm) was reached then the cells were incubated on ice 
for 15 min and harvested by centrifugation at 5 °C (4000 g, 10 min) (Thermo IEC 243 
Centra CL3R centrifuge, Thermo Fisher Scientific Inc, USA) and the supernatant 
solution was discarded. The pellets were re-suspended in Tfb 1 buffer (0.4 of original 
volume of over night culture medium) and incubated on ice for 15 min. Cells were 
harvested by centifugation as described above and the resulting pellet was re-suspended 
in Tfb 11 (0.04 of original volume of over night culture medium). The solution was 
incubated on ice for 20 min and then aliquoted to sterile Eppendorf tubes (100 µL) and 
flash frozen in liquid nitrogen for storage at -80 °C. 
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7.12 Protein production and purification 
7.12.1 Transformation into E. coli BL21 codon plus (DE3) – RIL 
competent cells 
 
1 µL of sequenced DNA was added to 100 µL of competent cells. The transformation 
mixture was incubated on ice for 30 min. After a heat shock at 42 °C for 45 s 1 mL of 
LB medium was added. The resulting mixture was incubated at 37 °C for 1 h. The 
resulting cells were harvested by microcentrifugation at 13000 rpm for 1 min. The pellet 
obtained was resuspended with in LB medium (20 µL) and spread onto LB agar plates 
containing ampicillin (0.18 mg/ mL LB-agar).  LB agar plates were kept at 37° C 
overnight. 
 
7.12.2 Large-scale expression 
 
A single colony transformed Pt-DNA was picked and used to inoculate 100 mL of LB 
medium containing ampicillin (0.27 µM). The culture was incubated overnight at 37 °C 
with shaking at 150 rpm in an Innova 43 shaker. The 5 mL overnight cultures were used 
to inoculate 6 x 500 mL of sterile LB medium containing ampicillin (0.27 µM). 
Cultures were incubated at 37 °C with shaking at 150 rpm. When the optical density 
(600 nm) reached 0.5-0.8, the cultures were induced with IPTG (0.5 mM) and grown for 
another 4 h at 37 °C. Cells were harvested by centrifugation at 5 °C (6000 g, 15 min). 
The supernatant solution was discarded and the pellets were stored at - 80°C. 
 
7.12.3 Base Extraction 
 
Frozen pellets of E. coli containing the over expressed enzyme were thawed and 
resuspended in cell lysis buffer. The resuspended cells were lysed by sonication on an 
ice bath (5 s pulse on followed by 10 s pulse off, repeated for a total of 4 min). The cell 
lysate was clarified by centrifugation at 5 °C (17000 g, 30 min: Pellet 1 (P 1) and 
supernatant solution 1 (SN 1) were obtained. Pellet 1 was resuspended in cell lysis 
buffer (100 mL). The pH of the solution was slowly adjusted to 12 by dropwise addition 
of NaOH (5 M) and then the basic solution was stirred for 30 min at 4 °C. βME (5 mM) 
was added and the pH changed back to pH 8 by dropwise addition of 1 M HCl. This 
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mixture was stirred for another 1 hour at 4 °C then the suspension was centrifuged 
(12000 rpm, 30 min). Finally protein was found in the resulting supernatant solution 2. 
 
7.12.4 Ion exchange chromatography  
 
Using buffers at various pH’s several attempts at purification of α-PS were attempted 
by ion exchange chromatography. The resins and pH conditions used were as follows:  
 
Resource S (6ml) at pH 7.0  
i. Start buffer: Tris buffer (20 mM Tris base, 5 mM EDTA, 5 mM βME, 
pH 7.0). 
ii. Elution buffer: start buffer + 1M NaCl 
 
Resource Q (8mL): at pH 8.0 
i. Start buffer: Tris buffer (20 mM Tris base, 5 mM EDTA, 5 mM βME, 
pH 8.0). 
ii. Elution buffer: start buffer + 1 M NaCl 
 
DEAE sepharose, Q sepharose and SP sepharose resins were also tried at different pH’s. 
For pH 6.2 and 7.0 phosphate buffer was used and for pH 8.0 and 8.8 cell lysis buffer 
was used. For each attempt a few grams of each resin was placed in an Eppendorf™ 
tubes then equilibrated with cell lysis buffer. Enzyme solution in cell lysis buffer (Tris-
base (50 mM), EDTA (5 mM), β-mercaptoethanol (5 mM) and 100 mL Glycerol (10% 
v/v), pH 8.0, 500 µL) was added to each sample and shaken gently for 5 min. As it was 
crude protein the enzyme concentration was not calculated. The mixture was then 
centrifuged for 1 min at 17,000 g and the flow through (supernatant solution) was 
decanted. Elution buffer containing 1M NaCl was then added to the resin pellet and 
mixed gently to elute the bound protein, after centrifugation for 1 min at 13,000 rpm the 
eluate (supernatant solution) was again decanted. After freeze-drying both the flow 
through and the eluate were redissolved in 20 µL cell lysis buffer and analysed by SDS-
PAGE 
 
For DEAE drip column chromatography a 3 × 1.5 cm diameter drip column was used. 
The column was pre-equilibrated with buffer. Proteins were eluted using NaCl in a step 
gradient (200 mM NaCl, 400 mM NaCl, 600 mM NaCl and 1 mM NaCl). Four column 
volumes (CV) of buffer passed through in each gradient. 1 mL of fractions was 
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collected. Absorbance was measured at 280nm and plotted against fractions. Aliquots 
were analysed by SDS PAGE. 
 
7.12.5 Ammonium sulphate precipitation. 
 
A saturated solution of (NH4)2SO4 was prepared. Different percentages of saturation 
were obtained (10% - 90%) by adding different amounts of saturated (NH4)2SO4 to 1 
mL of supernatant solution 2. For example 1.5 mL of saturated (NH4)2SO4  was added 
to obtain 60% saturation and 3.0 mL of  saturated (NH4)2SO4  was added to obtain 75%. 
The mixture was stirred for 1 h and then the resulting precipitate was collected by 
microcentrifugation at 13000 rpm for 30 min. The pellet obtained was resuspended in 
Tris buffer (20 mM Tris base, 5 mM EDTA, 5 mM βME, pH 8.0). Resuspended 
solutions arising from the pellet obtained from the different concentrations of 
ammonium sulfate used were analysed by SDS-PAGE. 
 
7.12.6 Hydrophobic interaction chromatography (HIC) 
 
Hydrophobic interaction chromatography was performed with the HiTrap Selection Kit 
(GE healthcare), according to the instruction manual.  This Selection Kit includes seven  
HIC columns with different hydrophobic characteristics were as follows: 
 
• HiTrap phenyl FF (1mL) (high substitution)  
• HiTrap phenyl FF (1mL) (low substitution) 
• HiTrap phenyl HP (1mL)  
• HiTrap butyl FF (1mL) 
• HiTrap butyl-S FF (1mL) 
• HiTrap Octyl FF (1mL) 
 
     1.  Start buffer: 50 mM sodium phosphate, 1M NaCl, pH 7.0 
2. Elution buffer: 50 mM sodium phosphate, pH 7.0 
  
Each column was pre-equilibrated with start buffer. In each case the SN 2 was added 
directly to the HIC column. Proteins were eluted with a NaCl gradient (1 M to 0 M) for 
15 column volumes using a flow rate of 1 ml/min. 1 mL fractions were collected.  
Fractions were analyzed by SDS-PAGE. 
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7.12.7 Size exclusion chromatography (SEC) 
 
Size exclusion chromatography was performed on a 10 × 300 mm bed diameter 
superdex-200 column (24 mL) (GE healthcare). Tris buffer (20 mM Tris, 5 mM EDTA, 
5 mM βME and 0.15 M NaCl at pH 8.0) was used to elute the material from the 
column. A flow rate of 0.5 ml/min was maintained for each elution. 1 mL of Fractions 
were collected and were analyzed by SDS-PAGE. A second attempt was carried out 
following the above protocol but adding 0.1 %( v/v) Tween 20 detergent to the buffer. 
 
7.12.8 Ni2+ affinity chromatography 
 
Binding Buffer: 100 mM Tris, 500 mM NaCl, 1mM imidazole, and 5 mM βME. 
Elution buffer: 100 mM Tris, 500 mM NaCl, 500 mM imidazole, and 5 mM βME. 
 
The supernatant solution from the base extraction step (SN2) was dialysed against 
binding buffer and the solution was loaded onto a Ni2+-SepharoseTM 6 Fast Flow drip 
column (GE Healthcare, 3 mL). After 10 min, the flow-through solution was collected 
and the column was washed with 10 column volumes (CV) of binding buffer. The 
protein was eluted with a gradient ranging from 5 to 500 mM imidazole (20 CV) 
followed by a wash at 500 mM imidazole (10 CV). Protein eluted at approximately 50-
150 mM imidazole. Fractions were analysed by SDS-PAGE and those corresponding to 
the correct molecular weight were pooled and dialysed overnight against 10 mM Tris-
Base, 5 mM βME, pH 7.5. 
 
 
7.13 Concentration of the dialysed protein using Amicon ultrafiltration 
 
The dialysed protein was transferred to an AmiconTM ultrafiltration apparatus 
containing a 30 kDa cutoff Millipore ultrafiltration membrane. The solution was 
concentrated at a pressure of 1.5 bar at 4 °C, to give a final volume of approximately 5-6 
mL. Concentrated protein sample was stored at -20 °C with 10 % (v/v) glycerol solution 
in water. 
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7.14 Determination of protein concentration 
 
The concentration of protein was measured using the Bradford method.144 Protein 
concentrations were measured at OD590/OD450 rather than single measurement at OD590 
to obtain more accurate and sensitive changes in the protein concentrations and thereby 
to acquire linearity.198 
 
7.14.1 Dye Reagent 
 
Coomassie brilliant blue G-250 (20 mg) was dissolved in 10 mL of ethanol and 20 mL 
of phosphoric acid (85 % w/v) was added. The solution was diluted with double 
distilled water to make the final volume 200 mL. The solution was filtered and stored at 
4 °C in the dark to protect it from light. 
 
7.14.2 Protein Determination 
 
1 mg/mL of BSA stock was prepared. The BSA protein diluted to a final concentration 
of 200 µL. A Calibration curve was obtained in the range of 0-100 µg/mL of BSA and 
straight line obtained by plotting OD590/OD450 as a function of BSA concentration. 
From the linear equation concentration of the protein was obtained. 
 
7.15 Enzyme characterization 
 
7.15.1 Assay of enzyme activity 
 
Kinetic assays were performed in a manner similar to that previously described within 
the group for aristolochene synthase.79 Assays (final volume 250 µL) were initiated by 
addition of a purified enzyme solution (0.4 µM) to 20-120 µM [1-3H]-geranyl 
diphosphate in Bis-Tris propane (100 mM), KCl (50 mM) and MgCl2 (100 mM), pH 
7.5). The reaction time and enzyme concentrations were optimized to make sure the 
reaction was in the initial linear phase. After incubation for 15 min, reactions were 
stopped by addition of 100 µL (100 mM) EDTA and overlaid with hexane (1 mL). The 
samples were vortexed for 10 s and the hexane layer was removed and the sample 
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extracted with further hexane (2 x 1 mL). The pooled hexane extracts were filtered 
through 40 mg of silica gel, emulsified with 15 mL of EcoscintTM O (National 
Diagnostics) and analyzed by scintillation counting (Packard 2500 TRTM) in 3H mode 
for 4 min per sample. Data were fitted to the Michaelis-Menton equation, V = (Vmax 
[S])/(KM  + [S]) using Systat Sigmaplot 10.  
 
7.16 GC-MS 
 
To test the activity of the purified enzyme and product profiles, the enzyme was 
incubated with substrate (1.6 mM), buffer (Bis-Tris propane (100 mM), KCl (50 mM) 
and MgCl2 (20 mM), pH 7.5) in a final volume of 0.5 mL. The assay solution was 
gently mixed with enzyme (10 µM) the reaction was overlaid with 1 mL of pentane and 
gently shaken overnight at room temperature. The organic layer was removed and the 
aqueous layer extracted with additional pentane (500 µL). The pooled pentane extracts 
were analyzed by GC-MS. 
GC-MS analyses were performed on a Hewlett Packard 6890 GC fitted with a J&W 
scientific DB-5MS column (30 m x 0.25 mm internal diameter) and a Micromass GCT 
Premiere mass spectrometer detecting in the range m/z 50-800 in EI+ mode with 
scanning once a second with a scan time of 0.9 s.  Injections (10 mm3) were performed 
in split mode (split ratio 5:1) at 50 °C. Chromatograms were begun with an oven 
temperature of 49 °C, which was held for 1 min and then increased at 4 °C min-1 for 
25.25 min up to 150 °C. 
 
7.17 Experimental 
 
(+)-Verbenone (13)  
 	  	  	  	  
In 27.0 mL assay buffer (Bis-Tris propane (100 mM), KCl (50 mM) and MgCl2 (20 
mM), pH 7.5) was added 1.6 mM GDP (16 mg, 40 mmol)  and was gently mixed with 
APS-His6 (4.0 mL, 4 mM). The resulting solution was overlaid with pentane (10 mL) 
and tightly sealed. The sealed vessel was then gently shaken overnight at room 
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temperature. The aqueous layer was then carefully removed and then further extracted 
with pentane (5 x 4 mL). To this enzymatically produced solution of (+)-α-pinene (4.9 
mg, 36 µmol) in pentane (30 mL) was added, drop-wise, tert-butyl hydroperoxide (70% 
wt. aqueous solution, 39.8 µL, 0.29 mmol) and Cr(CO)6 (15.8 mg, 72 µmol). To this 
mixture was added acetonitrile (4 mL) and the mixture was heated under reflux for 18 h. 
After cooling in ice the solution was filtered and the residue was washed with additional 
pentane (2 mL). The filtrate was extracted with 5% NaOH (3 x 5 mL), and the pooled 
aqueous extracts were back extracted with pentane (5 mL). The pooled fractions were 
dried with MgSO4, filtered and the solvent was carefully removed under reduced 
pressure. The residue was dissolved in hexane (1 mL) and (+)-verbenone purified by 
normal phase HPLC on an Agilent 1100 series system using a Waters Nova-PAK silica 
HR (3.9 mm x 300 mm) column, eluting with 1% isopropanol in hexane at 1 mL/min. 
Verbenone eluted at 8.84 min (3.0 mg, 50%). 
 
δH (400 MHz, CDCl3) 1.02 (s, 3 H, H-9); 1.47 (3 H, s, H-10); 2.00 (3H, d, J = 1.5 Hz, 
H-8); 2.10 - 2.08 (1 H, m, H-6); 2.42 (1 H, m, H-5); 2.70 - 2.62 (1 H, m, H-1); 2.91 - 
2.80 (1 H, m, H-6); 5.71(1 H, m, H-3); υmax/cm-1 (thin film) 3502, 3039, 2940, 2871, 
2360, 2342, 1683 and 1617; m/z (EI+) 150.1 (90%, M+), 135.1 (100, [M-CH3]+), 122.1 
(22), 107.1 (75), 91.1 (40), 71.1 (20), 67.1 (5); [α]20 = + 233.3 °dm-1cm3g-1  (c = 0.06, 
CHCl3). (lit. +258 (c = 1.0 in CHCl3). 	  	  
(2E,6E)-8-hydroxy-3,7-dimethylocta-2,6-dien-1-yl acetate (95) 	  	  	  	  	  
90% tert-butyl hydroperoxide (20.25 ml, 180 mmol) was poured into a magnetically 
stirred solution of selenium dioxide (0.112 g, 1 mmol) and salicylic acid (0.7 g, 5 
mmol) in dichloromethane (17.7 ml).  Geranyl acetate (10 g, 50 mmol) was added to the 
solution and was left to stir at room temperature for 24 hours.   
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When TLC (Hexane: EtOAc = 4: 1); confirmed the completion of the reaction, hexane 
(25 ml) was added and the dichloromethane was removed from the solution on the 
rotary evaporator.  Diethyl ether (50 ml) was added and the organic phase was washed 
with saturated sodium bicarbonate (3 x 20 ml) and brine (20 ml) before being dried with 
magnesium sulphate, filtered and reduced.   
The resulting oil was passed through a column.  A ratio of 19:1 hexane:ethyl acetate 
removed the unused starting material, geranyl acetate.  The ratio was then changed to 
4:1 to remove the aldehyde fractions, followed by the alcohol fractions.  Fractions were 
analysed by TLC.  All fractions were then pooled and concentrated under reduced 
pressure followed by high vacuum to yield 6.53 g (90.3%) of 95 and 0.51 g (7%) of 94. 
 
1H NMR of 95 (400 MHz, C6D6): δ 1.60 and 1.64 (2x3H, 2xs, 2xCH3, C9 and C10), 1.99 
(3H, s, CH3, C11), 1.95-2.15 (4H, m, CH2CH2, C4 and C5), 3.93 (2H, s, CH2, C8), 4.52 
(2H, d, JH,H=6 Hz, CH2, C1), 5.26-5.32 (2H, m, CH, C2 and C6). 
13C NMR of 95 (125 MHz, C6D6): 13.68 (C9), 16.40 (C10), 21.02 (C11), 25.67 (C5), 
39.05 (C4), 61.40 (C1), 68.93 (C8), 118.75 (C2), 125.34 (C6), 135.56 (C7), 138.20 (C3), 
170.19 (C12). 	  
(2E,6E)-3,7-dimethyl-8-oxoocta-2,6-dien-1-yl acetate (94) 	  	  	  	  	  
95 (2.5 g, 11.7 mmol) was oxidised to 94 by adding it to a solution of manganese 
dioxide (20 g, 230 mmol) in hexane (50 ml). The mixture was allowed to stir until TLC 
plates showed all the starting material had been converted. The solvent was then 
removed under reduced pressure followed by high vacuum to yield 2.45 g (98%) of 
colourless oil. 	  
1H NMR (250 MHz, C6D6): δ 1.50 and 1.67 (2x3H, 2xs, 2xCH3, C9 and C10), 1.81 (3H, 
s, CH3, C11), 1.87 (2H, t, JH,H=8 Hz, CH2, C4), 1.99-2.08 (2H, m, CH2, C5), 4.63 (2H, d, 
JH,H=7 Hz, CH2, C1), 5.37(1H, t, JH,H=5.8 Hz, CH, C6), 5.93 (1H, t, JH,H=7.3 Hz, CH, 
C2), 9.35 (1H, s, CH, C8). 
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13C NMR (125 MHz, C6D6): 9.124 (C9), 16.06 (C10), 20.50 (C11), 26.78 (C5), 37.73 
(C4), 60.88 (C1), 120.21 (C2), 139.78 (C7), 140.11 (C3), 152.00 (C6), 170.08 (C12), 
193.85 (C8). 	  
(2E,6E)-3,7-dimethylnona-2,6,8-trien-1-yl acetate (96) 	  	  
 	  
n-Butyl lithium solution (2.5 M in hexanes) (0.94 ml, 2.35 mmol) was added to a stirred 
solution of methyl triphenyl phosphonium bromide (838 mg, 2.35 mmol) at -10 oC in 
dry THF (10 ml) under nitrogen.  The resulting yellow solution was stirred for half an 
hour before a solution of 94 (100 mg, 0.470 mmol) in dry THF (5 ml) was added drop 
wise over duration of 5 minutes.  The solution was then allowed to warm to room 
temperature and was left to stir for another 48 hours under nitrogen.  When TLC 
(Hexane: EtOAc = 19: 1) confirmed all starting material had been converted, the 
reaction was quenched with saturated ammonium chloride solution (10 ml). 
The quenched mixture was diluted with 10 ml of water and the organic layer was 
collected.  The separated aqueous layer was extracted with diethyl ether until TLC 
showed the aqueous layer contained no product.  The pooled organic layers were 
washed with brine (20 ml), dried over magnesium sulphate, filtered and concentrated 
under reduced pressure.  The resulting yellow oil was purified by flash chromatography 
on silica gel (19:1, hexane: ethyl acetate) to yield 52 mg (52%) of colourless oil. 
 
1H NMR (250 MHz, CDCl3): δ 1.65 and 1.67 (2x3H, 2xs, 2xCH3, C10 and C11), 1.99 
(3H, s, CH3, C12), 2.00-2.25 (4H, m, CH2CH2, C4 and C5), 4.52 (2H, d, JH,H=7 Hz, CH2, 
C1), 4.87 (2H, d, JH,H=10.75 Hz, CHcis, C9), 5.02 (2H, d, JH,H=17.25 Hz, CHtrans, C9), 
5.29 (1H, t, JH,H=7.75 Hz, CH, C6), 5.38(1H, t, JH,H=7Hz, CH, C2), 6.29(1H, dd, 
JH,Htrans=17.25 Hz and JH,Hcis=10.75 Hz, CH, C8). 
13C NMR (125 MHz, CDCl3): 12.11(C10), 16.87 (C11), 21.50 (C12), 26.81 (C5), 39.44 
(C4), 61.75 (C1), 111.15 (C9), 118.99 (C2), 132.51 (C6), 134.74 (C7), 141.81 (C8), 
142.20 (C3), 171.57 (C13). 
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(2E,6E)-3,7-dimethylnona-2,6-dien-1-yl acetate (97) 	  	  	  	  	  
Triphenylphosphinerhodium chloride (43 mg, 0.047 mmol) was added to a solution of 
96 (100 mg, 0.473 mmol) in toluene (25 ml) and left to stir.  The reaction was left to stir 
and followed by GC and TLC (Hexane: EtOAc = 19: 1) until all the starting material 
had been converted.  The reaction was then quenched with water (10 ml).  The organic 
layer was separated and the aqueous layer was washed with diethyl ether (3 x 15 ml).  
The pooled organic layers were then washed with brine (20 ml), dried over magnesium 
sulphate and concentrated under reduced pressure.  The resulting oil was purified by 
flash chromatography (9:1, hexane: ethyl acetate) to give 62 mg (61.4%) of yellow oil.  
 
1H NMR (400 MHz, CDCl3): δ 0.91 (3H, t, JH,H=7.75 Hz, CH3, C9), 1.53 and 1.64 
(2x3H, 2xs, 2xCH3, C10 and C11), 1.91 (2H, q, JH,H=7.6 Hz, CH2, C8), 1.99 (3H, s, CH3, 
C12), 1.98-2.06 (2H, m, CH2CH2, C4 and C5), 4.52 (2H, d, JH,H=6.8 Hz, CH2, C1), 5.01 
(1H, t, JH,H=6.8 Hz, CH, C6), 5.28 (1H, t, JH,H=5.275 Hz, CH,C2). 
13C NMR (125 MHz, CDCl3): 13.19 (C9), 16.34 (C10), 16.89 (C11), 21.50 (C12), 26.51 
(C5), 32.74 (C8), 39.97 (C4), 61.83 (C1), 118.62 (C2), 122.54 (C6), 133.65 (C7), 142.76 
(C3), 170.2 (C13). 	  
(2E,6E)-3,7-dimethylnona-2,6-dien-1-ol (98) 	  	  	  	  	  
97 (100 mg, 0.47 mmol) was dissolved in a mixture of methanol (9 ml) and distilled 
water (1 ml).  The reaction was stirred at room temperature and lithium hydroxide (56.3 
mg, 2.35 mmol) was added. The reaction was monitored by TLC (Hexane: EtOAc = 4: 
1).  Once all the starting material had been converted the reaction mixture was 
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neutralised to pH 7 with hydrochloric acid.   The organic layer was then separated.  The 
aqueous layer was washed with diethyl ether (3x10 ml) and the pooled organic layers 
were washed with brine (10 ml), dried over magnesium sulphate and filtered.  The 
solvent was then concentrated under reduced pressure followed by high vacuum.  The 
resulting oil was purified by flash chromatography on silica gel (4:1 hexane to ethyl 
acetate) to give 76 mg (85%) of colourless oil.   
 
1H NMR (250 MHz, CDCl3): δ 1.00 (3H, t, JH,H=7. 5 Hz, CH3, C9), 1.63 and 1.72 
(2x3H, 2xs, 2xCH3, C10 and C11), 1.96-2.33 (6H, m, 3xCH2, C4 and C5 and C8), 4.19 
(2H, d, JH,H=7 Hz, CH2, C1), 5.08-5.15 (1H, m, CH, C6), 5.45 (1H, t, JH,H=8.25 Hz, CH, 
C2). 	  
(2E,6E)-1-bromo-3,7-dimethylnona-2,6-diene (99) 	  	  	  	  
Anhydrous triethylamine (0.72 mg, 0.1ml, 0.7 mmol) was added to a stirred solution of 
98 (80 mg, 0.5 mmol) in anhydrous THF (10 ml) at -45 oC, followed by methane 
sulfonyl chloride (0.82 mg, 0.08 ml, 0.7 mmol).  This mixture was stirred for 15 
minutes at -45 0C and then a solution of lithium bromide (165 mg, 1.9 mmol) in 
anhydrous THF (5 ml) was added.  This mixture was stirred under nitrogen for 2 hours, 
which after time TLC (Hexane: EtOAc = 9: 1) showed that all the starting material had 
been used.   
The reaction material was partitioned between hexane (20 ml) and water (20 ml).  The 
separated aqueous layer was washed twice more with hexane (2 x 20 ml).  The pooled 
hexane layers were washed with 1 M hydrochloric acid and brine.  This was then dried 
over magnesium sulphate, filtered and then reduced on a rotary evaporator followed by 
high vacuum. Crude bromide 99 was carried forward for the next reaction.  
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Synthesis of (2E,6E)-3,7-dimethylnona-2,6-dien-1-yl dihydrogen 
diphosphate (100) 	  	  	  	  
The crude bromide from the reaction 99 was re dissolved in acetonitrile (2 ml) and 
stirred under nitrogen as tris(tetrabutylammonium) hydrogen pyrophosphate (860 mg, 
0.95 mmol) was added.  Reaction was followed by TLC (H2O: NH4OH:(CH3)2CHOH = 
2:1:2) and stopped when the bromide spot on the plate had disappeared.  The solvent 
was then removed on the rotary evaporator.   
This was then dissolved in an ion exchange buffer (25 mmol NH4HCO3 with 2% 
isopropanol) and run through an ion exchange column to replace the 
tetrabutylammonium counter ions with ammonium ions.  The resulting compound was 
then run through a HPLC to collect the peaks containing the product.  This was then 
freeze-dried to give 85 mg (55% over the last two steps) of 100. 
 
1H NMR (500 MHz, D20): δ 0.82 (3H, t, JH,H=8 Hz, CH3, C9), 1.49 and 1.58 (2x3H, 
2xs, 2xCH3, C10 and C11), 1.82-2.05 (6H, m, 3xCH2, C4 and C5 and C8), 4.33 (2H, t, 
JH,H=7 Hz, CH2, C1), 5.08 (1H, t, JH,H=6. 5 Hz, CH, C6), 5.32 (1H, t, JH,H=6 Hz, CH, 
C2). 
13C NMR (125 MHz, D2O): 12.10 (C9), 12.90 (C10), 15.33 (C11), 26.51 (C5), 31.82 (C8), 
38.88 (C4), 63.06 (C1), 122.60 (C6), 139.45 (C7), 143.09 (C3) 
31P NMR (202.5 MHz, D2O): -10.17, -6.45. 
m/z (ES-) 327.1 (100%, [M +2H]-).  	  
(3E,7E)-9-bromo-3,7-dimethylnona-1,3,7-triene (102) 	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Anhydrous triethylamine (1.44 mg, 0.2 ml, 1.4 mmol) was added to a stirred solution of 
101 (160 mg, 1.0 mmol) in anhydrous THF (20 ml) at -45 oC, followed by methane 
sulfonyl chloride (1.6 mg, 0.16 ml, 1.4 mmol).  This mixture was stirred for 15 minutes 
at -45 0C and then a solution of lithium bromide (330 mg, 3.8 mmol) in anhydrous THF 
(5 ml) was added.  This mixture was stirred under nitrogen for 2 hours, which after time 
TLC (Hexane: EtOAc = 9: 1) showed that all the starting material had been used.   
The reaction material was partitioned between hexane (20 ml) and water (20 ml).  The 
separated aqueous layer was washed twice more with hexane (2 x 20 ml).  The pooled 
hexane layers were washed with 1 M hydrochloric acid and brine.  This was then dried 
over magnesium sulphate, filtered and then reduced on a rotary evaporator followed by 
high vacuum. Crude bromide 102 was carried forward for the next reaction.  	  
Synthesis of (2E,6E,8E)-3,7-dimethylnona-2,6,8-trien-1-yl dihydrogen 
diphosphate (103) 	  	  	  	  
The crude bromide from the reaction 102 was re dissolved in acetonitrile (2 ml) and 
stirred under nitrogen as tris(tetrabutylammonium) hydrogen pyrophosphate (860 mg, 
0.95 mmol) was added.  Reaction was followed by TLC (H2O: NH4OH:(CH3)2CHOH = 
2:1:2)  and stopped when the bromide spot on the plate had disappeared.  The solvent 
was then removed on the rotary evaporator. The product was then dissolved in an ion 
exchange buffer (25 mmol NH4HCO3 with 2% isopropanol) and run through an ion 
exchange column to replace the tetrabutylammonium counter ions with ammonium 
ions.  The resulting compound was then run through a HPLC to collect the peaks 
containing the product.  This was then freeze-dried to give 65 mg (45% over the last 
two steps) of 103. 
1H NMR (500 MHz, D20): δ 1.63 and 1.66 (2x3H, 2xs, 2xCH3, C10 and C11), 2.05-2.25 
(4H, m, CH2CH2, C4 and C5), 4.38 (2H, t, JH,H=6.4 Hz, CH2, C1), 4.91 (2H, d, 
JH,H=10.62 Hz, CHcis, C9), 5.09 (2H, d, JH,H=17.4 Hz, CHtrans, C9), 5.38 (1H, t, JH,H=6.0 
Hz, CH, C6), 5.51(1H, t, JH,H=6.5 Hz, CH, C2), 6.37(1H, dd, JH,Htrans=17.9 Hz and 
JH,Hcis=10.8 Hz, CH, C8). 
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13C NMR (125 MHz, D2O): 10.98 (C10), 15.63 (C11), 25.89 (C5), 38.37 (C4), 62.56 (C1), 
111.22 (C9), 120.31 (C2), 133.30 (C6), 134.72 (C7), 141.63 (C3), 141.27 (C8). 
m/z (ES-) 325.1 (100%, [M +2H]-). 	  
(E)-2-((3,7-dimethylocta-2,6-dien-1-yl)oxy)tetrahydro-2H-pyran (104) 	  	  	  	  
 
 
To a stirred solution of 89 (5 g, 32.5 mmol) in dry ether (30 mL) were added DHP (3.0 
g, 36 mmol) and TsOH (60 mg). The reaction was stirred under nitrogen for 18 hours. 
Once TLC (Hexane: EtOAc = 4: 1)	   showed completion of reaction, the mixture was 
quenched with Et3N (15 mL), extracted with a mix of Hexane:EtOAc (1:1) (3 x 20 mL). 
The organic layer was washed with water (10 mL) and brine (10 mL), dried over 
MgSO4, and concentrated under reduced pressure to give 6.5 g (88%) of 104. 
 
 
1H NMR (250 MHz; CDCl3): 1.5 (3x2H, m, C13, C14, C17 OTHP), 1.6 (3x3H, m, C1, C10, 
C11), 2.0 (2x2H, m, C4, C5), 3.5 (2H, m, C16 OTHP), 4.0 (2H, d, JH,H= 6.1 Hz, C8), 4.6 
(1H, t, JH,H= 7.5 Hz, C12 OTHP), 5.1 (1H, t, JH,H= 6.6 Hz, C3), 5.4 (1H, t, JH,H= 6.1 Hz, 
C7). 
13C NMR (125 MHz, CDCl3):17.5 (C11), 19.4 (C10), 20.2 (C14), 25.4 (C17), 26.0 (C1), 
26.7 (C4), 30.7 (C13), 39.5 (C5), 59.0 (C8), 62.6 (C16), 97.6 (C12), 120.7 (C7), 123.9 (C3), 
131.3 (C2), 139.8 (C6). 	  	  
(E)-3-bromo-2,6-dimethyl-8-((tetrahydro-2H-pyran-2-yl)oxy)oct-6-en-2-ol 
(105) 	  	  	  	  
 
 
To a stirred solution of 104 (2 g, 8.4 mmol) in THF/H20 (50/20 mL) at 5 °C was added 
NBS (1.6 g, 9.2 mmol) in 4 times. After 3 hours, the reaction was quenched with brine 
(20 mL). The aqueous layer was extracted with hexane (3 x 20 mL). The combined 
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organic layers were washed with brine (10 mL) and water (10 mL), dried over MgSO4, 
filtered and concentrated under reduced pressure. The resulting oil was purified by flash 
chromatography on silica gel (3:1 Hexane:EtOAc) to give  2 g (71%) of 3. 
 
1H NMR (400 MHz; CDCl3): 1.4 (3H, s, C10), 1.5 (3x2H, m, OTHP), 1.6 (2x3H, s, C1, 
C12), 2.0 (2x2H, m, C4, C5), 3.5 (2H, m, OTHP), 3.8 (1H, t, JH,H= 6.5 Hz, C3), 3.9 (2H, 
d, JH,H= 6.1 Hz, C8), 4.6 (1H, t, JH,H= 7.4 Hz, OTHP), 5.4 (1H, t, JH,H= 6.1 Hz, C7). 
13C NMR (125 MHz, CDCl3):16.3 (C11), 19.5 (C9), 20.9 (C9), 25.5 (C1), 26.4 (C12), 30.2 
(C4), 31.7 (C9), 38.1 (C5), 58.9 (C2), 63.4 (C8), 69.6 (C9), 72.4 (C3), 97.7 (C9), 122.0 
(C7), 138.2 (C6). 
 
(E)-2-((5-(3,3-dimethyloxiran-2-yl)-3-methylpent-2-en-1-
yl)oxy)tetrahydro-2H-pyran (106) 	  	  	  	  
 
 
To a solution of 105 (1 g, 3.0 mmol) in THF (20 mL) at 0 °C was added a solution of 
DBU (0.55 g, 3.6 mmol) in THF (3 mL). The reaction was stirred at 0 °C until the TLC 
(Hexane: EtOAc = 4: 1)	   showed completion of the reaction. The THF was removed 
under reduced pressure and the resulting oil was re-dissolved in hexane (10 mL). This 
was washed with water (3 x 5 mL) and brine (5 mL) before being dried over MgSO4, 
filtered and concentrated under reduced pressure to give 660 mg (87%) of 106. 
 
1H NMR (400 MHz; CDCl3): 1.1 (3H, s, C11), 1.2 (3H, s, C1), 1.5 (3x2H, m, OTHP), 1.6 
(3H, s, C10), 1.7 (2x2H, m, C4, C5), 2.5 (1H, t, JH,H= 6.8 Hz, C3), 3.4 (2H, m, OTHP), 
3.9 (2H, d, JH,H= 6.2 Hz, C8), 4.6 (1H, t, JH,H= 7.0 Hz, OTHP), 5.4 (1H, t, JH,H= 6.2 Hz, 
C7). 
13C NMR (125 MHz, CDCl3): 17.6 (C10), 18.7 (C9), 19.7 (C9), 24.7 (C1), 25.4 (C11), 
27.1 (C4), 30.6 (C9), 35.2 (C5), 59.1 (C2), 62.1 (C8), 63.4 (C9), 65.6 (C3), 97.8 (C9), 
121.3 (C7), 138.9 (C6). 	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(E)-4-methyl-6-((tetrahydro-2H-pyran-2-yl)oxy)hex-4-enal (107) 
 
 
 
 
 
 
To a solution of 106 (500 mg, 2.0 mmol) in Et2O (10 mL) at 0°C was added a solution 
of H5IO6 (0.5 g, 2.5 mmol) in THF (2 mL). After 30 minutes, the TLC (Hexane: EtOAc 
= 4: 1) showed completion of the reaction. The reaction was quenched with Na2S2O3 
(15 mL), the aqueous layer was extracted with Et2O (3 x 10 mL). The organic layers 
were washed with brine (10 mL), dried over MgSO4 and concentrated under reduced 
pressure to give 240 mg (57%) of 107. 	  
1H NMR (250 MHz; CDCl3):1.6 (3x2H, m, OTHP), 1.7 (3H, s, C9), 2.4(2H, t, JH,H= 6.8 
Hz, C4), 2.6 (2H, t, JH,H= 6.6 Hz, C3), 3.6 (2H, m, OTHP), 4.0 (2H, d, JH,H= 6.0 Hz, C7), 
4.9 (1H, t, JH,H= 6.9 Hz, OTHP), 5.4 (1H, t, JH,H= 6.0 Hz, C6), 9.7 (1H, t, JH,H= 7.1 Hz, 
C2). 
13C NMR (125 MHz, CDCl3): 16.5 (C9), 19.6 (C8), 25.6 (C8), 30.7 (C8), 31.6 (C4), 41.8 
(C3), 62.3 (C7), 63.5 (C8), 98.0 (C8), 121.8 (C6), 137.8 (C5), 201.9 (C2). 
 
(2Z,6E)-ethyl 2,6-dimethyl-8-((tetrahydro-2H-pyran-2-yl)oxy)octa-2,6-
dienoate (108) 	  	  	  	  	  
The ylide precursor, (CF3CH2O)2P(O)CH(CH3)CO2Et (0.45 g, 0.19 mmol, 1.0 equiv), 
was dissolved in THF (50 mL) and 18-crown-6 (2.5 g, 9.55 mmol, 5.0 equiv) was 
added. The solution was cooled to -78 °C and KHMDS (1.9 mL of a 1 M solution in 
THF, 1.91 mmol, 1.0 equiv) was added dropwise over 5 min. The reaction mixture was 
stirred for 15 min. 107 (0.34 g, 1.91 mmol, 1.0 equiv, dissolved in a small amount of 
THF) was added dropwise over 5 min. The reaction mixture was stirred for an 
additional 30 min and quenched with saturated ammonium chloride solution. The 
mixture was extracted 3x with portions of ethyl acetate, the combined organics were 
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washed with brine, dried over anhydrous sodium sulfate, and the volatiles were 
removed under reduced pressure. The residue was purified by column chromatography 
(10% hexanes/ethyl acetate) to give 0.46 g 108 in 78% yield as only the Z isomer, 
indicated by 1H NMR and NOE. 
1H NMR (250 MHz; CDCl3): 1.3 (2H, t, JH,H= 5.9 Hz, C13), 1.5 (3x2H, m, OTHP), 1.6 
(3H, s, C10), 1.8 (3H, s, C1), 2.1 (2H, t, JH,H= 6.6 Hz, C5), 2.5 (2H, t, JH,H= 6.8 Hz, C4), 
3.8 (2H, m, OTHP), 3.9 (2H, m, C12 ) 4.0 (2H, d, JH,H= 6.1 Hz, C8), 4.9 (1H, t, JH,H= 6.9 
Hz, OTHP), 5.3 (1H, t, JH,H= 6.0 Hz, C7), 5.4 (1H, t, JH,H= 6.0 Hz, C6), 5.8 (1H, t, JH,H= 
6.0 Hz, C6). 	  	  
(2Z,6E)-2,6-dimethyl-8-((tetrahydro-2H-pyran-2-yl)oxy)octa-2,6-dien-1-ol 
(109) 	  	  	  	  	  
The α,β-unsaturated ester 108 (2.8 g, 9.5 mmol, 1.0 equiv) was dissolved in THF (100 
mL) and cooled to -20 °C. DIBALH (5 mL of a 2.5 M solution in toluene, 40 mmol, 2.8 
equiv) was added dropwise over 10 min and the reaction mixture was stirred for 3 h. 
After completion was checked by TLC (Hexane: EtOAc = 3:1), the reaction was 
quenched by 10% HCl. The aqueous mixture was then extracted 3x with portions of 
diethyl ether, the combined organics were dried over anhydrous sodium sulfate and the 
volatiles were removed under reduced pressure. The residue was purified by column 
chromatography (4:1 hexanes/ethyl acetate) to give the 2.4 g of desired alcohol 109 in 
87% yield. 	  	  
(2Z,6E)-2,6-dimethyl-8-((tetrahydro-2H-pyran-2-yl)oxy)octa-2,6-dienal 
(110) 	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109 (2.2 g, 8.7 mmol) was oxidised to 110 by adding it to a solution of manganese 
dioxide (30g, 340 mmol) in hexane (150 ml).  The mixture was allowed to stir for 3 
hours until TLC (Hexane: EtOAc = 4: 1) showed all the starting material had been 
converted. The mixture was filtered through celite with hexane and the solvent was 
removed under reduced pressure followed by high vacuum to yield 1.9 g of 110 in 86% 
yield. 
1H NMR (250 MHz; CDCl3): 1.6 (3x2H, m, OTHP), 1.7 (3H, s, C9), 2.4(2H, t, JH,H= 6.5 
Hz, C4), 2.6 (2H, t, JH,H= 6.5 Hz C3), 3.6 (2H, m, OTHP), 4.0 (2H, d, JH,H= 6.2 Hz C7), 
4.9 (1H, t, JH,H= 7.5 Hz, OTHP), 5.4 (1H, t, JH,H= 6.2 Hz, C6), 9.7 (1H, t ,JH,H= 7.4 Hz, 
C2) 
13C NMR (500 MHz, CDCl3): 16.5 (C9), 19.6 (C8), 25.6 (C8), 30.7 (C8), 31.6 (C4), 41.8 
(C3), 62.3 (C7), 63.5 (C8), 98.0 (C8), 121.8 (C6), 137.8 (C5), 201.9 (C2) 	  
2-(((2E,6Z)-3,7-dimethylnona-2,6,8-trien-1-yl)oxy)tetrahydro-2H-pyran 
(111) 	  	  	  	  	  
n-Butyl lithium solution (2.5 M in hexanes) (0.8 ml, 2.0 mmol) was added to a stirred 
solution of methyl triphenyl phosphonium bromide (2.5 g, 7.01 mmol) at -10 oC in dry 
THF (30 ml) under nitrogen.  The resulting yellow solution was stirred for half an hour 
before a solution of 110 (1.0 g, 4.7 mmol) in dry THF (15 ml) was added drop wise 
over duration of 5 minutes.  The solution was then allowed to warm to room 
temperature and was left to stir for another 48 hours under nitrogen.  When TLC 
(Hexane: EtOAc = 9: 1) confirmed all starting material had been converted, the reaction 
was quenched with saturated ammonium chloride solution (20 ml). 
The quenched mixture was diluted with 20 ml of water and the organic layer was 
collected.  The separated aqueous layer was extracted with diethyl ether until TLC 
showed the aqueous layer contained no product.  The pooled organic layers were 
washed with brine (20 ml), dried over magnesium sulphate, filtered and concentrated 
under reduced pressure.  The resulting yellow oil was purified by flash chromatography 
on silica gel (19:1, hexane: ethyl acetate) to yield 0.5 g (52%) of 111. 
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(2E,6Z)-3,7-dimethylnona-2,6-dien-1-ol (112) 
 	  	  	  	  
Triphenylphosphinerhodium chloride (130 mg, 0.14 mmol) was added to a solution of 
111 (200 mg, 1.19 mmol) in toluene (6 ml) and left to stir.  The reaction was left to stir 
and followed by GC and TLC (Hexane: EtOAc = 4: 1) until all the starting material had 
been converted.  The reaction was then quenched with water (10 ml).  The organic layer 
was separated and the aqueous layer was washed with diethyl ether (3 x 15 ml).  The 
pooled organic layers were then washed with brine (20 ml), dried over magnesium 
sulphate and concentrated under reduced pressure. This mixture (140 mg, 0.5 mmol) in 
ethanol (4 mL) was treated with PPTS (14 mg, 0.05 mmol) for 2 hours to gives 68 mg 
(67.5%) 112 after both reactions.  	  
(2E,6Z)-1-bromo-3,7-dimethylnona-2,6-diene (113) 	  	  	  	  	  	  
Anhydrous triethylamine (0.48 mg, 0.07 ml, 0.46 mmol) was added to a stirred solution 
of 101 (53mg, 0.33 mmol) in anhydrous THF (6 ml) at -45 oC, followed by methane 
sulfonyl chloride (0.53 mg, 0.05 ml, 0.46 mmol).  This mixture was stirred for 15 
minutes at -45 0C and then a solution of lithium bromide (110 mg, 1.26 mmol) in 
anhydrous THF (3 ml) was added.  This mixture was stirred under nitrogen for 2 hours, 
which after time TLC (Hexane: EtOAc = 9: 1) showed that all the starting material had 
been used.   
The reaction material was partitioned between hexane (20 ml) and water (20 ml).  The 
separated aqueous layer was washed twice more with hexane (2 x 20 ml).  The pooled 
hexane layers were washed with 1 M hydrochloric acid and brine.  This was then dried 
over magnesium sulphate, filtered and then reduced on a rotary evaporator followed by 
high vacuum. Crude bromide 113 was carried forward for the next reaction.  
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Synthesis of (2E,6E)-3-methyl-7-ethylocta-2,6-dien-1-yl dihydrogen 
diphosphate (114) 	  	  	  	  	  	  
The crude bromide 113 was re dissolved in acetonitrile (2 ml) and stirred under nitrogen 
as tris (tetrabutylammonium) hydrogen pyrophosphate (860 mg, 0.95 mmol) was added.  
Reaction was followed by TLC (H2O: NH4OH:(CH3)2CHOH = 2:1:2) and stopped 
when the bromide spot on the plate had disappeared.  The solvent was then removed on 
the rotary evaporator.   
This was then dissolved in an ion exchange buffer (25 mmol NH4HCO3 with 2% 
isopropanol) and run through an ion exchange column to replace the 
tetrabutylammonium counter ions with ammonium ions.  The resulting compound was 
then run through a HPLC to collect the peaks containing the product.  This was then 
freeze-dried to gives 21 mg (45%) of 114 over the last two steps.  
 
1H NMR (500 MHz, D20): δ 0.85 (3H, t, JH,H=6 Hz, CH3, C11), 1.60 and 1.63 (2x3H, 
2xs, 2xCH3, C8 and C9), 1.90-2.08 (6H, m, 3xCH2, C4 and C5 and C8), 4.39 (2H, t, 
JH,H=6 Hz, CH2, C1), 5.16 (1H, t, JH,H=6. 5 Hz, CH, C6), 5.38 (1H, bs, CH, C2). 
13C NMR (125 MHz, D2O): 14.70 (C11), 18.21 (C9), 24.62 (C8), 26.95 (C10), 27.87 (C5), 
41.71 (C4), 65.09 (C1), 126.32 (C6), 142.30 (C7), 145.13 (C3) 
m/z (ES-) 327.07 (100%, [M +2H]-).  	  
(2E,6Z)-3,7-dimethylnona-2,6,8-trien-1-ol (115) 	  	  	  	  	  
The mixture 111 (200 mg, 0.7 mmol) in ethanol (8 mL) was treated with PPTS (18 mg, 
0.07 mmol) for 2 hours and the reaction was then quenched with water (20 ml).  The 
organic layer was separated and the aqueous layer was washed with diethyl ether (3 x 
20 ml).  The pooled organic layers were then washed with brine (20 ml), dried over 
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magnesium sulphate and concentrated under reduced pressure to give 92.6 mg (92%) of 
115. 
	  
(3Z,7E)-9-bromo-3,7-dimethylnona-1,3,7-triene (116) 	  	  	   	  	  
Anhydrous triethylamine (0.96 mg, 0.14 ml, 0.92 mmol) was added to a stirred solution 
of 115 (90mg, 0.70 mmol) in anhydrous THF (6 ml) at -45 oC, followed by methane 
sulfonyl chloride (1.0 mg, 0.1 ml, 0.92 mmol).  This mixture was stirred for 15 minutes 
at -45 0C and then a solution of lithium bromide (220 mg, 2.52 mmol) in anhydrous 
THF (3 ml) was added.  This mixture was stirred under nitrogen for 2 hours, which after 
time TLC (Hexane: EtOAc = 9: 1) showed that all the starting material had been used.   
The reaction material was partitioned between hexane (20 ml) and water (20 ml).  The 
separated aqueous layer was washed twice more with hexane (2x20 ml).  The pooled 
hexane layers were washed with 1 M hydrochloric acid and brine.  This was then dried 
over magnesium sulphate, filtered and then reduced on a rotary evaporator followed by 
high vacuum. Crude bromide 116 was carried forward for the next reaction.  	  	  
Synthesis of (2E,6E)-3-methyl-7ethyl-octa-2,6-dien-1-yl dihydrogen 
diphosphate (117) 	  	  	  	  	  
The crude bromide 116 was re dissolved in acetonitrile (4 ml) and stirred under nitrogen 
as tris(tetrabutylammonium) hydrogen pyrophosphate (1.7 g, 1.90 mmol) was added.  
The reaction was followed by TLC (H2O: NH4OH:(CH3)2CHOH = 2:1:2) and stopped 
when the bromide spot on the plate had disappeared.  The solvent was then removed on 
the rotary evaporator.   
This was then dissolved in an ion exchange buffer (25 mmol NH4HCO3 with 2% 
isopropanol) and run through an ion exchange column to replace the 
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tetrabutylammonium counter ions with ammonium ions.  The resulting compound was 
then run through a HPLC to collect the peaks containing the product.  This was then 
freeze-dried to give 60 mg (43%) of 117. 
 
1H NMR (500 MHz, D20): δ 1.72 and 1.79 (2x3H, 2xs, 2xCH3, C9 and C8),  1.99-2.26 
(4H, m, CH2CH2, C4 and C5), 4.39 (2H, m, CH2, C1), 5.05 (2H, d, JH,H=10.45 Hz, CHcis, 
C11), 5.24 (2H, d, JH,H=16.4 Hz, CHtrans, C9), 5.4-5.6 (2H, m, CH, C6 and C2 ), 6.84(1H, 
dd, JH,Htrans=17.2 Hz and JH,Hcis=10.6 Hz, CH, C10). 
13C NMR (125 MHz, D2O): 16.1 (C9), 18.66 (C8), 25.89 (C5), 38.8 (C4), 65.56 (C1), 
111.22 (C11), 123.4 (C2), 130.31 (C6), 134.5 (C7), 139.72 (C3), 141.63 (C3). 
m/z (ES-) 325.1 (100%, [M +2H]-). 	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